Document:

Exhibit 4.1

 

DESCRIPTION
OF The registrant’s SECURITIES

 

The following summary of the material terms of
the capital stock of Vicarious Surgical (formerly D8 Holdings Corp.) is not intended to be a complete summary of the rights and preferences
of such securities, and is qualified by reference to our Certificate of Incorporation (the “Charter”), our Amended and Restated
Bylaws (the “Bylaws”) and the warrant-related documents described herein, each of which are incorporated by reference as an
exhibit to the Annual Report on Form 10-K of which this Exhibit is a part, and certain provisions of Delaware law. We urge you to read
each of our Charter, our Bylaws and the warrant-related documents described herein in their entirety for a complete description of the
rights and preferences of our securities. Unless the context requires otherwise, all references to “we”, “us,”
“our,” the “Company” and “Vicarious Surgical” in this section refer solely to Vicarious Surgical (formerly
D8 Holdings Corp.) and not to our subsidiaries.

 

Authorized Capital Stock

 

We are authorized to issue 323,000,000 shares, consisting
of 300,000,000 shares of Class A common stock, par value $0.0001 per share, 22,000,000 shares of Class B common stock, par value $0.0001
per share, and 1,000,000 shares of preferred stock, par value $0.0001 per share.

 

Common Stock

 

Class A Common Stock

 

Voting Rights

 

Each holder of Class A common stock is entitled
to one vote for each share of Class A common stock held of record by such holder on all matters on which stockholders generally are entitled
to vote. The holders of Class A common stock do not have cumulative voting rights in the election of directors. Generally, all matters
to be voted on by stockholders must be approved by a majority (or, in the case of election of directors, by a plurality) of the votes
entitled to be cast by all stockholders present in person or represented by proxy, voting together as a single class. See the section
below entitled “Anti-Takeover Effects of the Charter, the Bylaws and Certain Provisions of Delaware Law — Supermajority
Provisions” for the list of matters of that will require approval of a supermajority of the then outstanding shares of our capital
stock.

 

Dividend Rights

 

Subject to preferences that may be applicable to
any outstanding preferred stock, the holders of shares of Class A common stock are entitled to receive ratably such dividends, if any,
as may be declared from time to time by our board of directors out of funds legally available for such purposes.

 

Liquidation Rights

 

In the event of any voluntary or involuntary liquidation,
dissolution or winding up of our affairs, the holders of Class A common stock are entitled to share ratably in all assets remaining after
payment of our debts and other liabilities, subject to prior distribution rights of preferred stock or any class or series of stock having
a preference over the Class A common stock, then outstanding, if any.

 

Other Rights

 

The holders of Class A common stock have no pre-emptive
or conversion rights or other subscription rights. There are no redemption or sinking fund provisions applicable to the Class A common
stock. The rights, preferences and privileges of holders of the Class A common stock will be subject to those of the holders of any shares
of the preferred stock that we may issue in the future.

 

     

     

    

 

Class B Common Stock

 

Voting Rights

 

The holders of Class B common stock are entitled
to twenty (20) votes for each share of Class B common stock held of record by such holder, on all matters on which stockholders generally
or holders of Class B common stock as a separate class are entitled to vote (whether voting separately as a class or together with one
or more classes of our capital stock). The holders of Class B common stock do not have cumulative voting rights in the election of directors.
Holders of Class B common stock will vote together with holders of Class A common stock as a single class on all matters presented to
our stockholders for their vote or approval. Generally, all matters to be voted on by stockholders must be approved by a majority (or,
in the case of election of directors, by a plurality) of the votes entitled to be cast by all stockholders present in person or represented
by proxy, voting together as a single class. See the section below entitled “Anti-Takeover Effects of the Charter, the Bylaws
and Certain Provisions of Delaware Law — Supermajority Provisions” for the list of matters of that will require approval
of a supermajority of the then outstanding shares of our capital stock.

 

Dividend Rights

 

With limited exceptions in the case of certain stock
dividends or disparate dividends approved by the affirmative vote of the holders of a majority of the Class A common stock and Class B
common stock, each voting separately as a class, holders of Class B common stock will share ratably together with each holder of Class
A common stock, if and when any dividend is declared by our board of directors out of funds legally available therefor, subject to restrictions,
whether statutory or contractual (including with respect to any outstanding indebtedness), on the declaration and payment of dividends
and to any restrictions on the payment of dividends imposed by the terms of any outstanding preferred stock or any class or series of
stock having a preference over, or the right to participate with, the Class B common stock with respect to the payment of dividends.

 

Optional Conversion

 

Holders of Class B common stock have the right to
convert shares of their Class B common stock into fully paid and non-assessable shares of Class A common stock, on a one-to-one basis,
at the option of the holder at any time upon written notice to us.

 

Mandatory Conversion

 

Holders of Class B common stock will have their
Class B common stock automatically converted into Class A common stock, on a one-to-one basis, upon the occurrence of any of the events
described below:

 

		(1)	Any sale, assignment, transfer, conveyance, hypothecation,
or other transfer or disposition, directly or indirectly, of any Class B common stock or any legal or beneficial interest in such share,
whether or not for value and whether voluntary or involuntary or by operation of law (including by merger, consolidation, or otherwise),
including, without limitation the transfer of a share of Class B common stock to a broker or other nominee or the transfer of, or entering
into a binding agreement with respect to, voting control over such share by proxy or otherwise, other than a permitted transfer.

 

		(2)	Upon the first date on which the Legacy Vicarious founders,
together with all other qualified stockholders, collectively cease to beneficially own at least 20% of the number of Class B common stock
(as such number of shares is equitably adjusted in respect of any reclassification, stock dividend, subdivision, combination, or recapitalization
of the Class B common stock) collectively beneficially owned by the Legacy Vicarious founders and permitted transferees of Class B common
stock as of the Closing.

 

		(3)	Upon the date specified by the affirmative vote of the holders
of at least two-thirds (2/3) of the outstanding shares of Class B common stock, voting as a separate class.

 

    2

     

    

 

		(4)	Upon the death or incapacity of a Legacy Vicarious founder
or a permitted transferee, with respect to the shares of Class B common stock held by such Legacy Vicarious founder or permitted transferee
of such Legacy Vicarious founder.

 

		(5)	Upon the date a Legacy Vicarious founder ceases to provide
services to us for any reason or no reason, with respect to the shares of Class B common stock held by such Legacy Vicarious founder
or permitted transferee of such Legacy Vicarious founder.

 

Liquidation Rights

 

In the event of any voluntary or involuntary liquidation,
dissolution or winding up of our affairs, the holders of Class B common stock are entitled to share ratably in all assets remaining after
payment of our debts and other liabilities, subject to prior distribution rights of preferred stock or any class or series of stock having
a preference over the Class B common stock, then outstanding, if any.

 

Other Rights

 

The holders of Class B common stock do not have
pre-emptive or subscription rights. There will be no redemption or sinking fund provisions applicable to the Class B common stock.

 

Preferred Stock

 

The Charter provides that the board of directors
have the authority, without action by the stockholders, to designate and issue shares of preferred stock in one or more classes or series,
and the number of shares constituting any such class or series, and to fix the voting powers, designations, preferences, limitations,
restrictions and relative rights of each class or series of preferred stock, including, without limitation, dividend rights, dividend
rates, conversion rights, exchange rights, voting rights, rights and terms of redemption, dissolution preferences, and treatment in the
case of a merger, business combination transaction, or sale of our assets, which rights may be greater than the rights of the holders
of the common stock. There are no shares of preferred stock outstanding as of March 1, 2022.

 

The purpose of authorizing the board of directors
to issue preferred stock and determine the rights and preferences of any classes or series of preferred stock is to eliminate delays associated
with a stockholder vote on specific issuances. The simplified issuance of preferred stock, while providing flexibility in connection with
possible acquisitions, future financings and other corporate purposes, could have the effect of making it more difficult for a third party
to acquire, or could discourage a third party from seeking to acquire, a majority of our outstanding voting stock. Additionally, the issuance
of preferred stock may adversely affect the holders of our common stock by restricting dividends on our common stock, diluting the voting
power of our common stock or subordinating the dividend or liquidation rights of our common stock. As a result of these or other factors,
the issuance of preferred stock could have an adverse impact on the market price of our common stock.

 

In September 2021, we completed the Transactions
contemplated by the Business Combination Agreement, pursuant to which Legacy Vicarious survived the Merger as a wholly-owned subsidiary
of D8. In connection with the Merger, D8 changed its name to “Vicarious Surgical Inc.” and Legacy Vicarious changed its name
to “Vicarious Surgical Operating Co.” On October 6, 2021, Legacy Vicarious changed its name from “Vicarious Surgical
Operating Co.” to “Vicarious Surgical US Inc.”

 

As a consequence of the Merger, on the Closing Date,
(i) Legacy Vicarious stockholders received shares of Class A common stock equal to the amount of shares of Legacy Vicarious capital stock
owned by such stockholder multiplied by 3.29831 for each share in such class of Legacy Vicarious capital stock that was issued and outstanding
immediately prior to the Closing, rounded to the nearest whole number of shares; (ii) the Legacy Vicarious founders received shares of
Class B common stock equal to the amount of shares of Legacy Vicarious Class A common stock owned by such Legacy Vicarious founder multiplied
by 3.29831 for each share in such class of Legacy Vicarious Class A common stock that was issued and outstanding immediately prior to
the Closing, rounded to the nearest whole number of shares; (iii) each option to purchase shares of Legacy Vicarious common stock, whether
vested or unvested, that was outstanding and unexercised as of immediately prior to the Closing was assumed by the us and became an option
(vested or unvested, as applicable) to purchase a number of shares of our Class A common stock equal to the number of shares of Legacy
Vicarious common stock subject to such option immediately prior to the Closing multiplied by 3.29831, rounded down to the nearest whole
number of shares, at an exercise price per share equal to the exercise price per share of such option immediately prior to the Closing
divided by 3.29831 and rounded up to the nearest whole cent; and (iv) each warrant to purchase shares of Legacy Vicarious Class B common
stock that was issued and outstanding prior to the Closing was assumed and converted into a warrant exercisable for shares of our Class
A common stock.

 

    3

     

    

 

Warrants

 

As of March 1, 2022, there were an aggregate of
17,248,621 outstanding public warrants and 10,400,000 outstanding private placement warrants, which entitle the holder to acquire Class
A common stock. Each whole warrant entitles the registered holder to purchase one share of Class A common stock at an exercise price of
$11.50 per full share, subject to adjustment as discussed below, beginning on October 17, 2021. Pursuant to the warrant agreement, a public
warrant holder may exercise its warrants only for a whole number of shares. This means that only an even number of warrants may be exercised
at any given time by a public warrant holder. However, except as set forth below, no public warrants will be exercisable for cash unless
we have an effective and current registration statement covering the shares of Class A common stock issuable upon exercise of the public
warrants and a current prospectus relating to such shares. Notwithstanding the foregoing, if a registration statement covering the shares
of Class A common stock issuable upon exercise of the public warrants is not effective within 60 business days from the completion of
the business combination on September 17, 2021, public warrant holders may, until such time as there is an effective registration statement
and during any period where we have failed to maintain an effective registration statement, exercise warrants on a cashless basis pursuant
to an available exemption from registration under the Securities Act. If an exemption from registration is not available, holders will
not be able to exercise their public warrants on a cashless basis. The public warrants will expire at 5:00 p.m., New York City Time on
the earlier to occur of: (i) five years from the completion of an initial business combination, (ii) the liquidation of us, if we fail
to complete a business combination, or (iii) the redemption date as fixed by us pursuant to the warrant agreement, if we elect to redeem
all warrants.

 

The private placement warrants are identical to
the public warrants except that the private placement warrants (including the shares of Class A common stock issuable upon exercise of
the private placement warrants) are not (i) exercisable for cash (even if a registration statement covering the shares of Class A common
stock issuable upon exercise of such warrants is not effective) or on a cashless basis, at the holder’s option and (ii) redeemable
by us, in each case so long as they are still held by the initial purchasers or their respective affiliates.

 

We may call the warrants for redemption (excluding
the private placement warrants), in whole and not in part, at a price of $0.01 per warrant:

 

		●	at any time while the warrants are exercisable;

 

		●	upon not less than 30 days’ prior written notice of
redemption to each public warrant holder;

 

		●	if, and only if, the reported last sale price of the shares
of Class A common stock equals or exceeds $18.00 per share, for any 20 trading days within a 30-day trading period ending on the third
business day prior to the notice of redemption to public warrant holders; and

 

		●	if, and only if, there is a current registration statement
in effect with respect to the shares of Class A common stock underlying such warrants at the redemption date and for the entire 30-day
trading period referred to above and continuing each day thereafter until the date of redemption.

 

We may call the warrants for redemption (excluding
the private placement warrants), in whole and not in part, at a price of $0.10 per warrant:

 

		●	at any time while the warrants are exercisable;

 

		●	upon not less than 30 days’ prior written notice of
redemption to each public warrant holder; provided that holders will be able to exercise their warrants on a cashless basis prior to
redemption and receive that number of shares determined by reference to the table below, based on the redemption date and the “fair
market value” (as defined below) of the shares of Class A common stock except as otherwise described below;

 

    4

     

    

 

		●	if, and only if, the reported last sale price of the shares
of Class A common stock equals or exceeds $10.00 per share, for any 20 trading days within a 30-day trading period ending on the third
business day prior to the notice of redemption to public warrant holders;

 

		●	if the closing price of the Class A common stock for any
20 trading days within a 30-trading day period ending on the third trading day prior to the date on which the notice of redemption is
sent to the public warrant holders is less than $18.00 per share, the private placement warrants must be concurrently called for redemption
on the same terms as the outstanding public warrants; and

 

		●	if, and only if, there is a current registration statement
in effect with respect to the Class A common stock underlying such warrants at the redemption date and for the entire 30-day trading
period referred to above and continuing each day thereafter until the date of redemption.

 

Beginning on the date the notice of redemption is
given and until the public warrants are redeemed or exercised, holders may elect to exercise their public warrants on a cashless basis.
The numbers in the table below represent the number of shares of Class A common stock that a warrant holder will receive upon such cashless
exercise in connection with a redemption by us pursuant to this redemption feature, based on the “fair market value” of the
Class A common stock on the corresponding redemption date (assuming holders elect to exercise their warrants and such warrants are not
redeemed for $0.10 per warrant), determined for these purposes based on the volume-weighted average price of the Class A common stock
during the 10 trading days immediately following the date on which the notice of redemption is sent to the holders of warrants, and the
number of months that the corresponding redemption date precedes the expiration date of the warrants, each as set forth in the table below.
We will provide warrant holders with the final fair market value no later than one business day after the 10-trading day period described
above ends.

 

	Redemption Fair Market Value of Class A common stock (period to expiration of warrants)	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Redemption Date	 	≤$10.00	 	 	$11.00	 	 	$12.00	 	 	$13.00	 	 	$14.00	 	 	$15.00	 	 	$16.00	 	 	$17.00	 	 	≥$18.00	 
	60 months	 	 	0.261	 	 	 	0.281	 	 	 	0.297	 	 	 	0.311	 	 	 	0.324	 	 	 	0.337	 	 	 	0.348	 	 	 	0.358	 	 	 	0.361	 
	57 months	 	 	0.257	 	 	 	0.277	 	 	 	0.294	 	 	 	0.310	 	 	 	0.324	 	 	 	0.337	 	 	 	0.348	 	 	 	0.358	 	 	 	0.361	 
	54 months	 	 	0.252	 	 	 	0.272	 	 	 	0.291	 	 	 	0.307	 	 	 	0.322	 	 	 	0.335	 	 	 	0.347	 	 	 	0.357	 	 	 	0.361	 
	51 months	 	 	0.246	 	 	 	0.268	 	 	 	0.287	 	 	 	0.304	 	 	 	0.320	 	 	 	0.333	 	 	 	0.346	 	 	 	0.357	 	 	 	0.361	 
	48 months	 	 	0.241	 	 	 	0.263	 	 	 	0.283	 	 	 	0.301	 	 	 	0.317	 	 	 	0.332	 	 	 	0.344	 	 	 	0.356	 	 	 	0.361	 
	45 months	 	 	0.235	 	 	 	0.258	 	 	 	0.279	 	 	 	0.298	 	 	 	0.315	 	 	 	0.330	 	 	 	0.343	 	 	 	0.356	 	 	 	0.361	 
	42 months	 	 	0.228	 	 	 	0.252	 	 	 	0.274	 	 	 	0.294	 	 	 	0.312	 	 	 	0.328	 	 	 	0.342	 	 	 	0.355	 	 	 	0.361	 
	39 months	 	 	0.221	 	 	 	0.246	 	 	 	0.269	 	 	 	0.290	 	 	 	0.309	 	 	 	0.325	 	 	 	0.340	 	 	 	0.354	 	 	 	0.361	 
	36 months	 	 	0.213	 	 	 	0.239	 	 	 	0.263	 	 	 	0.285	 	 	 	0.305	 	 	 	0.323	 	 	 	0.339	 	 	 	0.353	 	 	 	0.361	 
	33 months	 	 	0.205	 	 	 	0.232	 	 	 	0.257	 	 	 	0.280	 	 	 	0.301	 	 	 	0.320	 	 	 	0.337	 	 	 	0.352	 	 	 	0.361	 
	30 months	 	 	0.196	 	 	 	0.224	 	 	 	0.250	 	 	 	0.274	 	 	 	0.297	 	 	 	0.316	 	 	 	0.335	 	 	 	0.351	 	 	 	0.361	 
	27 months	 	 	0.185	 	 	 	0.214	 	 	 	0.242	 	 	 	0.268	 	 	 	0.291	 	 	 	0.313	 	 	 	0.332	 	 	 	0.350	 	 	 	0.361	 
	24 months	 	 	0.173	 	 	 	0.204	 	 	 	0.233	 	 	 	0.260	 	 	 	0.285	 	 	 	0.308	 	 	 	0.329	 	 	 	0.348	 	 	 	0.361	 
	21 months	 	 	0.161	 	 	 	0.193	 	 	 	0.223	 	 	 	0.252	 	 	 	0.279	 	 	 	0.304	 	 	 	0.326	 	 	 	0.347	 	 	 	0.361	 
	18 months	 	 	0.146	 	 	 	0.179	 	 	 	0.211	 	 	 	0.242	 	 	 	0.271	 	 	 	0.298	 	 	 	0.322	 	 	 	0.345	 	 	 	0.361	 
	15 months	 	 	0.130	 	 	 	0.164	 	 	 	0.197	 	 	 	0.230	 	 	 	0.262	 	 	 	0.291	 	 	 	0.317	 	 	 	0.342	 	 	 	0.361	 
	12 months	 	 	0.111	 	 	 	0.146	 	 	 	0.181	 	 	 	0.216	 	 	 	0.250	 	 	 	0.282	 	 	 	0.312	 	 	 	0.339	 	 	 	0.361	 
	9 months	 	 	0.090	 	 	 	0.125	 	 	 	0.162	 	 	 	0.199	 	 	 	0.237	 	 	 	0.272	 	 	 	0.305	 	 	 	0.336	 	 	 	0.361	 
	6 months	 	 	0.065	 	 	 	0.099	 	 	 	0.137	 	 	 	0.178	 	 	 	0.219	 	 	 	0.259	 	 	 	0.296	 	 	 	0.331	 	 	 	0.361	 
	3 months	 	 	0.034	 	 	 	0.065	 	 	 	0.104	 	 	 	0.150	 	 	 	0.197	 	 	 	0.243	 	 	 	0.286	 	 	 	0.326	 	 	 	0.361	 
	0 months	 	 	—	 	 	 	—	 	 	 	0.042	 	 	 	0.115	 	 	 	0.179	 	 	 	0.233	 	 	 	0.281	 	 	 	0.323	 	 	 	0.361	 

 

    5

     

    

 

The exact fair market value and redemption date
may not be set forth in the table above, in which case, if the fair market value is between two values in the table or the redemption
date is between two redemption dates in the table, the number of shares of Class A common stock to be issued for each warrant exercised
will be determined by a straight-line interpolation between the number of shares set forth for the higher and lower fair market values
and the earlier and later redemption dates, as applicable, based on a 365 or 366-day year, as applicable. For example, if the volume-weighted
average price of Class A common stock during the 10 trading days immediately following the date on which the notice of redemption is sent
to the holders of the warrants is $11.00 per share, and at such time there are 57 months until the expiration of the warrants, holders
may choose to, in connection with this redemption feature, exercise their warrants for 0.277 shares of Class A common stock for each whole
warrant. For an example where the exact fair market value and redemption date are not as set forth in the table above, if the volume-weighted
average price of the Class A common stock during the 10 trading days immediately following the date on which the notice of redemption
is sent to the holders of the warrants is $13.50 per share, and at such time there are 38 months until the expiration of the warrants,
holders may choose to, in connection with this redemption feature, exercise their warrants for 0.298 shares of Class A common stock for
each whole warrant. In no event will the warrants be exercisable on a cashless basis in connection with this redemption feature for more
than 0.361 shares of Class A common stock per warrant (subject to adjustment). Finally, as reflected in the table above, if the warrants
are out of the money and about to expire, they cannot be exercised on a cashless basis in connection with a redemption by us pursuant
to this redemption feature, since they will not be exercisable for any shares of Class A common stock.

 

The right to exercise will be forfeited unless the
public warrants are exercised prior to the date specified in the notice of redemption. On and after the redemption date, a record holder
of a public warrant will have no further rights except to receive the redemption price for such holder’s public warrant upon surrender
of such public warrant.

 

The redemption criteria for the public warrants
have been established at a price which is intended to provide public warrant holders a reasonable premium to the initial exercise price
and provide a sufficient differential between the then-prevailing share price and the warrant exercise price so that if the share price
declines as a result of a redemption call, the redemption will not cause the share price to drop below the exercise price of the warrants.

 

If we call the warrants for redemption as described
above, our management will have the option to require all holders that wish to exercise warrants to do so on a “cashless basis.”
In such event, each holder would pay the exercise price by surrendering the warrants for that number of shares of Class A common stock
equal to the quotient obtained by dividing (x) the product of the number of shares underlying the warrants, multiplied by the difference
between the exercise price of the warrants and the “fair market value” (defined below) by (y) the fair market value. The “fair
market value” will mean the average reported last sale price of the Class A common stock for the 10 trading days ending on
the third trading day prior to the date on which the notice of redemption is sent to the holders of warrants. Whether we will exercise
our option to require all holders to exercise their warrants on a “cashless basis” will depend on a variety of factors including
the price of the Class A common stock at the time the warrants are called for redemption, our cash needs at such time and concerns regarding
dilutive share issuances.

 

The warrants are issued under a warrant agreement
between Continental Stock Transfer & Trust Company, as warrant agent and us. The warrant agreement provides that the terms of the
warrants may be amended without the consent of any holder for the purpose of (a) curing any ambiguity or to correct any defective provision
or mistake, including to conform the provisions of the warrant agreement to the description of the terms of the warrants and the warrant
agreement set forth in this Exhibit, (b) adjusting the provisions relating to cash dividends on ordinary shares as contemplated by and
in accordance with the warrant agreement or (c) adding or changing any provisions with respect to matters or questions arising under the
warrant agreement as the parties to the warrant agreement may deem necessary or desirable and that the parties deem to not adversely affect
the rights of the registered holders of the warrants, provided that the approval by the holders of at least 50% of the then-outstanding
public warrants is required to make any change that adversely affects the interests of the registered holders of public warrants, and,
solely with respect to any amendment to the terms of the private placement warrants, 50% of the then outstanding private placement warrants.

 

    6

     

    

 

The exercise price and number of shares of Class
A common stock issuable on exercise of the warrants may be adjusted in certain circumstances including in the event of a share dividend,
extraordinary dividend or our recapitalization, reorganization, merger or consolidation. However, the warrants will not be adjusted for
issuances of Class A common stock at a price below their respective exercise prices. We are also permitted, in our sole discretion, to
lower the exercise price (but not below the par value of a share of Class A common stock) at any time prior to the expiration date for
a period of not less than 15 business days; provided, however, that we provide at least 5 days’ prior written notice of such reduction
to registered holders of the warrants and that any such reduction will be applied consistently to all of the warrants. Any such reduction
in the exercise price will comply with any applicable regulations under the U.S. federal securities laws, including Rule 13e-4 under the
Exchange Act generally and Rule 13e-4(f)(1)(i) specifically.

 

The warrants may be exercised upon surrender of
the warrant certificate on or prior to the expiration date at the offices of the warrant agent, with the exercise form on the reverse
side of the warrant certificate completed and executed as indicated, accompanied by full payment of the exercise price, by certified or
official bank check payable to us, for the number of warrants being exercised. The public warrant holder will not have the rights or privileges
of holders of Class A common stock and any voting rights until they exercise their warrants and receive Class A common stock. After the
issuance of Class A common stock upon exercise of the warrants, each holder will be entitled to one vote for each share held of record
on all matters to be voted on by shareholders.

 

Except as described above, no public warrants will
be exercisable and we will not be obligated to issue Class A common stock unless at the time a holder seeks to exercise such warrant,
a prospectus relating to the Class A common stock issuable upon exercise of the warrants is current and the Class A common stock have
been registered or qualified or deemed to be exempt under the securities laws of the state of residence of the holder of the warrants.
Under the terms of the warrant agreement, we have agreed to use our best efforts to meet these conditions and to maintain a current prospectus
relating to the Class A common stock issuable upon exercise of the warrants until the expiration of the warrants. However, we cannot assure
you that we will be able to do so and, if we do not maintain a current prospectus relating to the Class A common stock issuable upon exercise
of the warrants, holders will be unable to exercise their warrants and we will not be required to settle any such warrant. If the prospectus
relating to the Class A common stock issuable upon the exercise of the warrants is not current or if the Class A common stock is not qualified
or exempt from qualification in the jurisdictions in which the holders of the warrants reside, we will not be required to net cash settle
or cash settle the warrant exercise, the warrants may have no value, the market for the warrants may be limited and the warrants may expire
worthless.

 

Public warrant holders may elect, at their sole
option and discretion, to be subject to a restriction on the exercise of their warrants such that an electing public warrant holder (and
his, her or its affiliates) would not be able to exercise their warrants to the extent that, after giving effect to such exercise, such
holder (and his, her or its affiliates) would beneficially own in excess of 4.9% or 9.8% (as specified by the holder) of the Class A common
stock outstanding. Notwithstanding the foregoing, any person who acquires a warrant with the purpose or effect of changing or influencing
the control of us, or in connection with or as a participant in any transaction having such purpose or effect, immediately upon such acquisition
will be deemed to be the beneficial owner of the underlying Class A common stock and not be able to take advantage of this provision.

 

No fractional shares will be issued upon exercise
of the warrants. If, upon exercise of the warrants, a holder would be entitled to receive a fractional interest in a share (as a result
of a subsequent share dividend payable in shares of common stock, or by a split up of the Class A common stock or other similar event),
we will, upon exercise, round down to the nearest whole number the number of Class A common stock to be issued to the public warrant holder.

 

Registration Rights

 

On April 15, 2021 and September 9, 2021, D8 entered
into subscription agreements with certain qualified institutional buyers and accredited investors (the “PIPE Investors”),
pursuant to which, among other things, the PIPE Investors purchased shares of Class A common stock immediately prior to the Closing and
the PIPE Investors are entitled to certain registration rights. In particular, we agreed to, within thirty (30) calendar days after the
Closing, file with the SEC (at our sole cost and expense) a registration statement registering the resale of the shares of Class A common
stock issued to the PIPE Investors, and to use our commercially reasonable efforts to have such registration statement declared effective
as soon as practicable after the filing thereof, but no later than the earlier of (i) the 60th calendar day (or the 120th
calendar day if the SEC notifies us that it will “review” such registration statement) following the Closing and (ii) the
10th business day after the date we are notified (orally or in writing) by the SEC that such registration statement will not
be “reviewed” or will not be subject to further review.

 

    7

     

    

 

At the Closing, we entered into an amended and restated
registration rights agreement (the “Amended and Restated Registration Rights Agreement”) with the Sponsor and D8’s independent
directors (the “Sponsor Group Holders”), and certain Legacy Vicarious stockholders (the “Legacy Vicarious Holders”),
pursuant to which, among other things, the Sponsor Group Holders and the Legacy Vicarious Holders agreed not to effect any sale or distribution
of any of our equity securities held by any of them (except with respect to shares of Class A common stock acquired in open market transactions
or by Sponsor Group Holders pursuant to the PIPE Financing) during the lock-up period described therein and were granted certain registration
rights, on the terms and subject to the conditions therein, with respect to their respective shares of our common stock which is set forth
as follows:

 

		●	Registration rights.    Promptly,
but in any event within thirty (30) days following the Closing of the Business Combination, we were required to use our commercially
reasonable efforts to file a registration statement under the Securities Act to permit the public resale of all registrable securities
as permitted by Rule 415 of the Securities Act and to cause such registration statement to be declared effective as soon as practicable
after the filing thereof, but in no event later than sixty (60) days following the filing deadline (or ninety (90) days following the
filing deadline if the registration statement is reviewed by and receives comments from the SEC). At any time at which we have an effective
shelf registration statement with respect to a holder’s registrable securities, any such holder may request to sell all or a portion
of their registrable securities pursuant to an underwritten offering pursuant to such shelf registration statement, provided that such
holder(s) reasonably expect any such sales to generate aggregate gross proceeds in excess of $50 million or reasonably expect to sell
all of the registrable securities held by such holder, but in no event for aggregate gross proceeds of less than $10 million in gross
proceeds. We will enter into an underwriting agreement with a managing underwriter or underwriters selected by the initiating holder(s),
after consultation with us, and will take all such other reasonable actions as are requested by the managing underwriter to expedite
or facilitate the disposition of such registrable securities.

 

		●	Demand registration rights.    At
any time after the Closing of the Business Combination, if we do not have an effective registration statement outstanding, we will be
required, upon the written request of the holders of at least a majority-in-interest of the then-outstanding registrable securities
held by the Sponsor Group Holders or the Legacy Vicarious Holders, as soon as practicable but not more than forty-five (45) days
after receipt of such written request, to file a registration statement and to effect the registration of all or part of their registrable
securities. We are not obligated to effect more than an aggregate of three (3) registrations pursuant to a demand registration request.

 

		●	Piggyback registration rights.    At
any time after the Closing of the Business Combination, if we propose to file a registration statement under the Securities Act to register
any of its equity securities, or securities or other obligations exchangeable or convertible into equity securities, or to conduct a
public offering, either for our own account or for the account of any other person, subject to certain exceptions and reductions as described
in the Amended and Restated Registration Rights Agreement, then we will give written notice of such proposed filing to the holders of
registrable securities as soon as practicable but not less than 10 days before the anticipated filing of such registration statement.
Upon the written request of any holder of registrable securities in response to such written notice, we will, in good faith, cause such
registrable securities to be included in the registration statement and use our commercially reasonable efforts to cause the underwriters
of any proposed underwritten offering to include such holders’ registrable securities on the same terms and conditions as any similar
securities of ours included in such registration.

 

    8

     

    

 

Anti-Takeover Effects of the Charter, the Bylaws and Certain Provisions
of Delaware Law

 

The Charter, the Bylaws and the Delaware General
Corporation Law (the “DGCL”) contain provisions, which are summarized in the following paragraphs, which are intended to enhance
the likelihood of continuity and stability in the composition of our board of directors and to discourage certain types of transactions
that may involve an actual or threatened acquisition of us. These provisions are intended to avoid costly takeover battles, reduce our
vulnerability to a hostile change of control or other unsolicited acquisition proposal, and enhance the ability of our board of directors
to maximize stockholder value in connection with any unsolicited offer to acquire us. However, these provisions may have the effect of
delaying, deterring or preventing a merger or acquisition of us by means of a tender offer, a proxy contest or other takeover attempt
that a stockholder might consider in its best interest, including attempts that might result in a premium over the prevailing market price
for the shares of Class A common stock. The Charter provides that any action required or permitted to be taken by our stockholders must
be effected at a duly called annual or extraordinary general meeting of such stockholders and may not be effected by any consent in writing
by such holders except that any action required or permitted to be taken by holders of Class B common stock, voting separately as a class,
or, to the extent expressly permitted to do so by the certificate of designation relating to one or more series of our preferred stock,
voting separately as a series or separately as a class with one or more other such series, may be taken without a meeting, without prior
notice and without a vote, if a consent or consents, setting forth the action so taken, are signed by the holders of outstanding shares
of the relevant class or series having not less than the minimum number of votes that would be necessary to authorize or take such action
at a meeting at which all shares entitled to vote thereon were present and voted and are delivered to us in the manner forth in Section
228 of the DGCL.

 

Authorized but Unissued Capital Stock

 

Delaware law does not require stockholder approval
for any issuance of authorized shares. However, the listing requirements of the NYSE, which would apply if and so long as the Class A
common stock remains listed on the NYSE, require stockholder approval of certain issuances equal to or exceeding 20% of the then outstanding
voting power or then outstanding number of shares of Class A common stock. Additional shares that may be issued in the future may be used
for a variety of corporate purposes, including future public offerings, to raise additional capital or to facilitate acquisitions. One
of the effects of the existence of our unissued and unreserved capital stock may be to enable our board of directors to issue shares to
persons friendly to current management, which issuance could render more difficult or discourage an attempt to obtain control of us by
means of a merger, tender offer, proxy contest or otherwise and thereby protect the continuity of management and possibly deprive stockholders
of opportunities to sell their shares of Class A common stock at prices higher than prevailing market prices.

 

Blank Check Preferred Stock

 

The Charter provides for 1,000,000 authorized shares
of preferred stock. The existence of authorized but unissued shares of preferred stock may enable our board of directors to render more
difficult or to discourage an attempt to obtain control of us by means of a merger, tender offer, proxy contest or otherwise. For example,
if in the due exercise of its fiduciary obligations, our board of directors were to determine that a takeover proposal is not in the best
interests of us or our stockholders, our board of directors could cause shares of preferred stock to be issued without stockholder approval
in one or more private offerings or other transactions that might dilute the voting or other rights of the proposed acquirer or insurgent
stockholder or stockholder group.

 

In this regard, the Charter grants our board of
directors broad power to establish the rights and preferences of authorized and unissued shares of preferred stock. The issuance of shares
of preferred stock could decrease the amount of earnings and assets available for distribution to holders of shares of common stock. The
issuance may also adversely affect the rights and powers, including voting rights, of the holders of shares of common stock and may have
the effect of delaying, deterring or preventing a change in control of us.

 

Election of Directors and Vacancies

 

The Charter provides that our board of directors
will determine the number of directors who will serve on the board of directors. Subject to the Director Nomination Agreement, the exact
number of directors will be fixed from time to time by a majority of our board of directors. The Charter also provides that our board
of directors will be declassified and will consist of one class of directors only, whose term will continue to the first annual meeting
of stockholders following the date of the Closing, and, thereafter, all directors will be elected annually and will be elected for one
year terms expiring at the next annual meeting of our stockholders. There will be no limit on the number of terms a director may serve
on our board of directors.

 

    9

     

    

 

In addition, the Charter provides that any vacancy
on our board of directors, including a vacancy that results from an increase in the number of directors or a vacancy that results from
the removal of a director with cause, may be filled only by a majority of the directors then in office, subject to the provisions of the
Director Nomination Agreement and any rights of the holders of our preferred stock.

 

Quorum

 

The Bylaws provide that at any meeting of our board
of directors, a majority of the total number of directors then in office constitutes a quorum for the transaction of business.

 

No Cumulative Voting

 

Under Delaware law, the right to vote cumulatively
does not exist unless the certificate of incorporation expressly authorizes cumulative voting. The Charter does not authorize cumulative
voting.

 

General Stockholder Meetings

 

The Charter provides that special meetings of stockholders
may be called only by or at the direction of our board of directors.

 

Requirements for Advance Notification of Stockholder Meetings, Nominations
and Proposals

 

The Bylaws establish advance notice procedures with
respect to stockholder proposals and the nomination of candidates for election as directors, other than nominations made by or at the
direction of our board of directors or a committee of our board of directors. For any matter to be “properly brought” before
a meeting, a stockholder will have to comply with advance notice requirements and provide us with certain information. Generally, to be
timely, a stockholder’s notice must be received at our principal executive offices not less than 90 days nor more than 120 days
prior to the first anniversary date of the immediately preceding annual meeting of stockholders (for the purposes of the first annual
meeting of our stockholders following the adoption of the Bylaws, the date of the preceding annual meeting will be deemed to be June 1,
2021). The Bylaws allow our board of directors to adopt rules and regulations for the conduct of a meeting of the stockholders as it deems
appropriate, which may have the effect of precluding the conduct of certain business at a meeting if the rules and regulations are not
followed. These provisions may also defer, delay or discourage a potential acquirer from conducting a solicitation of proxies to elect
the acquirer’s own slate of directors or otherwise attempting to influence or obtain control of us.

 

Supermajority Provisions

 

The Charter and the Bylaws provide that our board
of directors is expressly authorized to make, alter, amend, change, add to, rescind or repeal, in whole or in part, the Bylaws without
a stockholder vote in any matter not inconsistent with the laws of the State of Delaware or the Charter and subject to the rights of the
parties to the Director Nomination Agreement.

 

The DGCL provides generally that the affirmative
vote of a majority of the outstanding shares entitled to vote thereon, voting together as a single class, is required to amend a corporation’s
certificate of incorporation, unless the certificate of incorporation requires a greater percentage. The Charter provides that the following
provisions therein may be amended, altered, repealed or rescinded only by the affirmative vote of the holders of at least 662/3% in voting power
all the then outstanding shares of our capital stock entitled to vote thereon, voting together as a single class:

 

		●	the provision regarding our board of directors being authorized
to establish one or more series of preferred stock with such powers, preferences and relative, participating, optional and other special
rights, including voting rights, dividend rights, conversion rights, redemption privileges and liquidation preferences as our board of
directors may determine;

 

		●	the provision regarding our board of directors being authorized
to amend the Bylaws without a stockholder vote;

 

		●	the provisions regarding filling vacancies on our board of
directors and newly created directorships;

 

		●	the provisions regarding resignation and removal of directors;
the provisions regarding calling special meetings of stockholders;

 

    10

     

    

 

		●	the provisions regarding stockholder action by written consent;
and

 

		●	the amendment provision requiring that the above provisions
be amended only with a 662/3% supermajority vote.

 

These provisions may have the effect of deterring
hostile takeovers or delaying or preventing changes in control of us or our management, such as a merger, reorganization or tender offer.
These provisions are intended to enhance the likelihood of continued stability in the composition of our board of directors and its policies
and to discourage certain types of transactions that may involve an actual or threatened acquisition of us. These provisions are designed
to reduce our vulnerability to an unsolicited acquisition proposal. The provisions are also intended to discourage certain tactics that
may be used in proxy fights. However, such provisions could have the effect of discouraging others from making tender offers for our common
stock and, as a consequence, may inhibit fluctuations in the market price of our common stock that could result from actual or rumored
takeover attempts. Such provisions may also have the effect of preventing changes in management.

 

Exclusive Forum

 

The Charter will provide that, unless we consent
in writing to the selection of an alternative forum, the Court of Chancery of the State of Delaware (or if such court does not have subject
matter jurisdiction, the federal district court of the State of Delaware) will be the sole and exclusive forum for (i) any derivative
action or proceeding brought on behalf of us, (ii) any action asserting a claim of breach of a fiduciary duty owed by any current or former
director, officer, other employee or stockholder of ours to us or our stockholders, (iii) any action asserting a claim (a) arising
pursuant to any provision of Delaware law, the Charter or the Bylaws or (b) as to which Delaware law confers jurisdiction on the
Court of Chancery of the State of Delaware or (iv) any action asserting a claim against us or any current or former director, officer,
employee, stockholder or agent of ours governed by the internal affairs doctrine of the law of the State of Delaware. To the fullest extent
permitted by law, any person or entity purchasing or otherwise acquiring or holding any interest in shares of our capital stock will be
deemed to have notice of and consented to the forum provisions in the Charter. In addition, the Charter provides that, unless we consent
in writing to the selection of an alternate forum, the federal district courts of the United States of America shall, to the fullest extent
permitted by applicable law, be the exclusive forum for the resolution of any complaint asserting a cause of action arising under the
Securities Act. This provision in the Charter will not address or apply to claims that arise under the Exchange Act; however, Section
27 of the Exchange Act creates exclusive federal jurisdiction over all suits brought to enforce any duty or liability created by the Exchange
Act or the rules and regulations thereunder. However, it is possible that a court could find our forum selection provisions to be inapplicable
or unenforceable, and stockholders cannot waive compliance with the federal securities laws and the rules and regulations thereunder.
Although we believe this provision will benefit us by providing increased consistency in the application of Delaware law in the types
of lawsuits to which it applies, the provision may have the effect of discouraging lawsuits against our directors and officers.

 

Conflicts of Interest

 

Delaware law permits corporations to adopt provisions
renouncing any interest or expectancy in certain opportunities that are presented to the corporation or its officers, directors or stockholders.
The Charter, to the maximum extent permitted from time to time by Delaware law, renounces any interest or expectancy that we have in,
or right to be offered an opportunity to participate in, specified business opportunities that are from time to time presented to a member
of our board of directors who is not an employee of ours or our subsidiaries, or any employee or agent of such member, other than someone
who is an employee of ours or our subsidiaries. The Charter does not renounce our interest in any business opportunity that is expressly
offered to a non-employee director solely in his or her capacity as a director or officer of ours.

 

    11

     

    

 

Limitations on Liability and Indemnification of Officers and Directors

 

The DGCL authorizes corporations to limit or eliminate
the personal liability of directors to corporations and their stockholders for monetary damages for breaches of directors’ fiduciary
duties, subject to certain exceptions. The Charter includes a provision that eliminates the personal liability of directors for monetary
damages for any breach of fiduciary duty as a director, except to the extent such exemption from liability or limitation thereof is not
permitted under the DGCL. The effect of these provisions is to eliminate our rights and the rights of our stockholders, through stockholders’
derivative suits on our behalf, to recover monetary damages from a director for breach of fiduciary duty as a director, including breaches
resulting from grossly negligent behavior. However, exculpation does not apply to any director if the director has acted in bad faith,
knowingly or intentionally violated the law, authorized illegal dividends or redemptions or derived an improper benefit from his or her
actions as a director.

 

The limitation of liability provision in the Charter
and the Bylaws may discourage stockholders from bringing a lawsuit against directors for breach of their fiduciary duty. These provisions
also may have the effect of reducing the likelihood of derivative litigation against directors and officers, even though such an action,
if successful, might otherwise benefit us and our stockholders. In addition, your investment may be adversely affected to the extent we
pay the costs of settlement and damage awards against directors and officers pursuant to any indemnity agreements that may be entered
into. We believe that this provision, liability insurance and any indemnity agreements that may be entered into are necessary to attract
and retain talented and experienced directors and officers.

 

Insofar as indemnification for liabilities arising
under the Securities Act may be permitted to our directors, officers and controlling persons pursuant to the foregoing provisions, or
otherwise, we have been advised that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities
Act and is, therefore, unenforceable.

 

There is currently no pending material litigation
or proceeding involving any of our respective directors, officers or employees for which indemnification is sought.

 

Transfer Agent and Registrar

 

The transfer agent for our capital stock is Continental
Stock Transfer & Trust Company.

 

Stock Exchange Listing

 

Our Class A common stock and warrants to purchase
Class A common stock are listed for trading on the NYSE under the symbol “RBOT” and “RBOT WS”, respectively.

 

 

12Exhibit 10.10

 

VICARIOUS SURGICAL INC.

 

2021 EQUITY INCENTIVE PLAN

 

	 	1.	DEFINITIONS.

 

Unless otherwise specified
or unless the context otherwise requires, the following terms, as used in this Vicarious Surgical Inc. 2021 Equity Incentive Plan, have
the following meanings:

 

Administrator means the Board of Directors,
unless it has delegated power to act on its behalf to the Committee, in which case the term “Administrator” means the Committee.

 

Affiliate means a corporation or other
entity, which, for purposes of Section 424 of the Code, is a parent or subsidiary of the Company, direct or indirect.

 

Agreement means a written or electronic
document setting forth the terms of a Stock Right delivered pursuant to the Plan, in such form as the Administrator shall approve.

 

Agreement and Plan of Merger means that
certain Agreement and Plan of Merger, dated as of April 15, 2021 by and among D8 Holdings Corp., Snowball Merger Sub, Inc., Vicarious
Surgical Inc. and Adam Sachs, in his capacity as the Stockholder Representative.

 

Board of Directors
means the Board of Directors of the Company.

 

Cause means, with respect to a Participant
(a) dishonesty with respect to the Company or any Affiliate, (b) the Administrator’s determination that the Participant failed to
carry out, or comply with any lawful and reasonable directive of the Board of Directors or the Participant’s immediate supervisor or the
Participant’s insubordination, substantial malfeasance or non-feasance of duty, (c) unauthorized disclosure of confidential information
or trade secrets of the Company or any Affiliate, (d) breach by a Participant of any provision of any employment, severance, consulting,
advisory, nondisclosure, non-competition or similar agreement between the Participant and the Company or any Affiliate or any material
written policy of the Company or any Affiliate, including, without limitation, any award agreement entered into pursuant to this Plan,
(e) the occurrence of any act or omission by the Participant that could reasonably be expected to result in (or has resulted in)
the Participant’s conviction, plea of no contest, plea of nolo contendere, or imposition of unadjudicated probation for any felony or
indictable offense or crime involving moral turpitude, (f) the Participant’s commission of an act of fraud, embezzlement, misappropriation,
misconduct, or breach of fiduciary duty against the Company or any Affiliate, and (g) conduct substantially prejudicial to the business
of the Company or any Affiliate; provided, however, that any provision in an agreement between a Participant and the Company or an Affiliate,
which contains a conflicting definition of Cause for termination and which is in effect at the time of such termination, shall supersede
this definition with respect to that Participant. The determination of the Administrator as to the existence of Cause will be conclusive
on the Participant and the Company.

 

Class A Common Stock means shares of the
Company’s Class A common stock, $0.0001 par value per share.

 

Class B Common Stock means shares of the
Company’s Class B common stock, $0.0001 par value per share.

 

Closing means the date on which the transactions
contemplated by the Agreement and Plan of Merger are consummated.

 

Code means the United States Internal Revenue
Code of 1986, as amended including any successor statute, regulation and guidance thereto.

 

Committee means the committee of the Board
of Directors, if any, to which the Board of Directors has delegated power to act under or pursuant to the provisions of the Plan.

 

     

     

    

 

Common Stock means the Class A Common Stock
and the Class B Common Stock, individually or collectively, as the context requires.

 

Company means Vicarious Surgical Inc.,
a Delaware corporation.

 

Consultant means any natural person who
is an advisor or consultant who provides bona fide services to the Company or its Affiliates, provided that such services are not in connection
with the offer or sale of securities in a capital raising transaction, and do not directly or indirectly promote or maintain a market
for the Company’s or its Affiliates’ securities.

 

Corporate Transaction means a merger, consolidation,
or sale of all or substantially all of the Company’s assets or the acquisition of all of the outstanding voting stock of the Company
(or similar transaction) in a single transaction or a series of related transactions by a single entity, other than a transaction to merely
change the state of incorporation or in which the Company is the surviving corporation. Where a Corporate Transaction involves a tender
offer that is reasonably expected to be followed by a merger (as determined by the Administrator), the Corporate Transaction will be deemed
to have occurred upon consummation of the tender offer.

 

Disability or Disabled means permanent
and total disability as defined in Section 22(e)(3) of the Code.

 

Employee means any employee of the Company
or of an Affiliate (including, without limitation, an employee who is also serving as an officer or director of the Company or of an Affiliate),
designated by the Administrator to be eligible to be granted one or more Stock Rights under the Plan.

 

Exchange Act
means the United States Securities Exchange Act of 1934, as amended.

 

Fair Market Value
of a Share of Class A Common Stock means:

 

If the Class A Common Stock is listed on a national
securities exchange or traded in the over-the-counter market and sales prices are regularly reported for the Class A Common Stock, the
closing or, if not applicable, the last price of the Class A Common Stock on the composite tape or other comparable reporting system for
the trading day on the applicable date and if such applicable date is not a trading day, the last market trading day prior to such date;

 

If the Class A Common Stock is not traded on a
national securities exchange but is traded on the over-the-counter market, if sales prices are not regularly reported for the Class A
Common Stock for the trading day referred to in clause (1), and if bid and asked prices for the Class A Common Stock are regularly
reported, the mean between the bid and the asked price for the Class A Common Stock at the close of trading in the over-the-counter market
for the most recent trading day on which Class A Common Stock was traded on the applicable date and if such applicable date is not a trading
day, the last market trading day prior to such date; and

 

If the Class A Common Stock is neither listed
on a national securities exchange nor traded in the over-the-counter market, such value as the Administrator, in good faith, shall determine
in compliance with applicable laws.

 

ISO means a stock option intended to qualify
as an incentive stock option under Section 422.

 

Non-Qualified Option
means a stock option which is not intended to qualify as an ISO.

 

Option means an ISO or Non-Qualified Option
granted under the Plan.

 

Participant means an Employee, director
or Consultant of the Company or an Affiliate to whom one or more Stock Rights are granted under the Plan. As used herein, “Participant”
shall include “Participant’s Survivors” where the context requires.

 

Performance-Based Award means a Stock Grant
or Stock-Based Award which vests based on the attainment of written Performance Goals as set forth in Paragraph 9 hereof.

 

    2

     

    

 

Performance Goals means performance goals
determined by the Committee in its sole discretion and set forth in an Agreement. The satisfaction of Performance Goals shall be subject
to certification by the Committee. The Committee has the authority to take appropriate action with respect to the Performance Goals (including,
without limitation, making adjustments to the Performance Goals or determining the satisfaction of the Performance Goals in connection
with a Corporate Transaction) provided that any such action does not otherwise violate the terms of the Plan.

 

Plan means this
Vicarious Surgical Inc. 2021 Equity Incentive Plan.

 

Prior Plan means
the Vicarious Surgical Inc. 2014 Stock Incentive Plan.

 

SAR means a
stock appreciation right.

 

Section 409A
means Section 409A of the Code.

 

Section 422
means Section 422 of the Code.

 

Securities Act
means the United States Securities Act of 1933, as amended.

 

Shares means shares of the Class A Common
Stock as to which Stock Rights have been or may be granted under the Plan or any shares of capital stock into which the Shares are changed
or for which they are exchanged within the provisions of Paragraph 3 of the Plan. The Shares issued under the Plan may be authorized
and unissued shares or shares held by the Company in its treasury, or both.

 

Stock-Based Award means a grant by the
Company under the Plan of an equity award or an equity based award, which is not an Option, or a Stock Grant.

 

Stock Grant
means a grant by the Company of Shares under the Plan.

 

Stock Right means an ISO, a Non-Qualified
Option, a Stock Grant or a Stock-Based Award or a right to Shares or the value of Shares of the Company granted pursuant to the Plan.

 

Substitute Award means an award issued
under the Plan in substitution for one or more equity awards of an acquired company that are converted, replaced or adjusted in connection
with the acquisition.

 

Survivor means a deceased Participant’s
legal representatives and/or any person or persons who acquired the Participant’s rights to a Stock Right by will or by the laws
of descent and distribution.

 

	 	2.	PURPOSES OF THE PLAN.

 

The Plan is intended to encourage
ownership of Shares by Employees and directors of and certain Consultants to the Company and its Affiliates in order to attract and retain
such people, to induce them to work for the benefit of the Company or of an Affiliate and to provide additional incentive for them to
promote the success of the Company or of an Affiliate. The Plan provides for the granting of ISOs, Non-Qualified Options, Stock Grants
and Stock-Based Awards.

 

	 	3.	SHARES SUBJECT TO THE PLAN.

 

(a) The number of Shares
that may be issued from time to time pursuant to this Plan shall be the sum of: (i) 6,590,000 shares of Class A Common Stock, and (ii)
that number of shares issuable upon exercise of outstanding options under the Prior Plan, determined immediately prior to the Closing,
multiplied by the Fully Diluted Adjusted Merger Consideration (as defined in the Agreement and Plan of Merger).

 

    3

     

    

 

(b) If an Option ceases
to be “outstanding”, in whole or in part (other than by exercise), or if the Company shall reacquire (at not more than its
original issuance price) any Shares issued pursuant to a Stock Grant or Stock-Based Award, or if any Stock Right expires or is forfeited,
cancelled, or otherwise terminated or results in any Shares not being issued, the unissued or reacquired Shares which were subject to
such Stock Right shall again be available for issuance from time to time pursuant to this Plan; provided, however, that the number of
Shares underlying any awards under the Plan that are retained or repurchased on the exercise of an Option or the vesting or issuance of
any Stock Right to cover the exercise price and/or tax withholding required by the Company in connection with vesting shall not be added
back to the Shares available for issuance under the Plan; and provided, further that, in the case of ISOs, the foregoing provisions shall
be subject to any limitations under the Code. In addition, any Shares repurchased using exercise price proceeds will not be available
for issuance under the Plan.

 

(d) The maximum number
of Shares available for grant under the Plan as ISOs will be equal to 18,384,074. The limits set forth in this Paragraph 3 will be construed
to comply with the applicable requirements of Section 422.

 

(e) The Administrator
may grant Substitute Awards under the Plan. To the extent consistent with the requirements of Section 422 and the regulations thereunder
and other applicable legal requirements (including applicable stock exchange requirements), Shares issued in respect of Substitute Awards
will be in addition to and will not reduce the shares available under the Plan. Notwithstanding the foregoing, if any Substitute Award
is settled in cash or expires, becomes unexercisable, terminates or is forfeited to or repurchased by the Company without the issuance
or retention of Shares, the Shares previously subject to such Award will not be available for future issuance under the Plan. The Administrator
will determine the extent to which the terms and conditions of the Plan apply to Substitute Awards, if at all; provided, however, that
Substitute Awards will not be subject to the limits described in Paragraph 4(c) below.

 

	 	4.	ADMINISTRATION OF THE PLAN.

 

The Administrator of the Plan
will be the Board of Directors, except to the extent the Board of Directors delegates its authority to the Committee, in which case the
Committee shall be the Administrator. Subject to the provisions of the Plan, the Administrator is authorized to:

 

(a) Interpret the provisions
of the Plan and all Stock Rights and to make all rules and determinations which it deems necessary or advisable for the administration
of the Plan;

 

(b) Determine which Employees,
directors and Consultants shall be granted Stock Rights;

 

(c) Determine the number
of Shares for which a Stock Right or Stock Rights shall be granted; provided, however, that in no event shall the aggregate grant date
fair value (determined in accordance with ASC 718) of Stock Rights to be granted and any other cash compensation paid to any non-employee
director in any calendar year, exceed $750,000, increased to $1,000,000 in the year in which such non-employee director initially joins
the Board of Directors.

 

(d) Specify the terms
and conditions upon which a Stock Right or Stock Rights may be granted provided that no dividends or dividend equivalents shall be paid
on any Stock Right prior to the vesting of the underlying Shares.

 

(e) Amend any term or
condition of any outstanding Stock Right, provided that (i) such term or condition as amended is not prohibited by the Plan and (ii) any
such amendment shall not impair the rights of a Participant under any Stock Right previously granted without such Participant’s
consent or in the event of death of the Participant the Participant’s Survivors.

 

(f) Determine and make
any adjustments in the Performance Goals included in any Performance-Based Awards; and

 

(g) Adopt any sub-plans
applicable to residents of any specified jurisdiction as it deems necessary or appropriate in order to comply with or take advantage of
any tax or other laws applicable to the Company, any Affiliate or to Participants or to otherwise facilitate the administration of the
Plan, which sub-plans may include additional restrictions or conditions applicable to Stock Rights or Shares issuable pursuant to a Stock
Right;

 

Subject to the foregoing, the interpretation and
construction by the Administrator of any provisions of the Plan or of any Stock Right granted under it shall be final, unless otherwise
determined by the Board of Directors, if the Administrator is the Committee. In addition, if the Administrator is the Committee, the Board
of Directors may take any action under the Plan that would otherwise be the responsibility of the Committee.

 

    4

     

    

 

To the extent permitted under
applicable law, the Board of Directors or the Committee may allocate all or any portion of its responsibilities and powers to any one
or more of its members and may delegate all or any portion of its responsibilities and powers to any other person selected by it. The
Board of Directors or the Committee may revoke any such allocation or delegation at any time. Notwithstanding the foregoing, only the
Board of Directors or the Committee shall be authorized to grant a Stock Right to any director of the Company or to any “officer”
of the Company as defined by Rule 16a-1 under the Exchange Act.

 

	 	5.	ELIGIBILITY FOR PARTICIPATION.

 

The Administrator will, in
its sole discretion, name the Participants in the Plan; provided, however, that each Participant must be an Employee, director or Consultant
of the Company or of an Affiliate at the time a Stock Right is granted. Notwithstanding the foregoing, the Administrator may authorize
the grant of a Stock Right to a person in anticipation of such person becoming an Employee, director or Consultant of the Company or of
an Affiliate, provided, that the actual grant of such Stock Right shall be conditioned upon such person becoming eligible to become a
Participant at or prior to the time of the execution of the Agreement evidencing such Stock Right. ISOs may be granted only to Employees.
Non-Qualified Options, Stock Grants and Stock-Based Awards may be granted to any Employee, director or Consultant of the Company or an
Affiliate. The granting of any Stock Right to any individual shall neither entitle that individual to, nor disqualify that individual
from, participation in any other grant of Stock Rights or any grant under any other benefit plan established by the Company or any Affiliate
for Employees, directors or Consultants.

 

	 	6.	TERMS AND CONDITIONS OF OPTIONS.

 

Each Option shall be set forth
in an Option Agreement duly executed by the Company and, to the extent required by law or requested by the Company, by the Participant.
The Administrator may provide that Options be granted subject to such terms and conditions, consistent with the terms and conditions specifically
required under this Plan, as the Administrator may deem appropriate including, without limitation, subsequent approval by the shareholders
of the Company of this Plan or any amendments thereto. The Option Agreements shall be subject to at least the following terms and conditions:

 

(a) Non-Qualified
Options: Each Option intended to be a Non-Qualified Option shall be subject to the terms and conditions which the Administrator determines
to be appropriate and in the best interest of the Company, subject to the following minimum standards for any such Non-Qualified Option:

 

(i) Exercise Price: Each
Option Agreement shall state the exercise price (per share) of the Shares covered by each Option which exercise price shall be determined
by the Administrator and shall be at least equal to the Fair Market Value per share of the Class A Common Stock on the date of grant of
the Option.

 

(ii) Number of Shares: Each
Option Agreement shall state the number of Shares to which it pertains.

 

(iii) Vesting: Each Option
Agreement shall state the date or dates on which it first is exercisable and the date after which it may no longer be exercised, and may
provide that the Option rights accrue or become exercisable in installments over a period of months or years, or upon the occurrence of
certain performance conditions or the attainment of stated goals or events.

 

(iv) Term of Option: Each
Option shall terminate not more than ten years from the date of the grant or at such earlier time as the Option Agreement may provide.

 

(b) ISOs: Each
Option intended to be an ISO shall be issued only to an Employee who is deemed to be a resident of the United States for tax purposes,
and shall be subject to the following terms and conditions, with such additional restrictions or changes as the Administrator determines
are appropriate but not in conflict with Section 422 and relevant regulations and rulings of the Internal Revenue Service:

 

(i) Minimum Standards: The
ISO shall meet the minimum standards required of Non-Qualified Options, as described in Paragraph 6(a) above, except clause (i) and (iv)
thereunder.

 

(ii) Exercise Price: Immediately
before the ISO is granted, if the Participant owns, directly or by reason of the applicable attribution rules in Section 424(d) of
the Code:

 

	 	A.	10% or less of the total combined voting power of all classes of stock of the Company or an Affiliate, the exercise price per share of the Shares covered by each ISO shall not be less than 100% of the Fair Market Value per share of the Class A Common Stock on the date of grant of the Option; or

 

	 	B.	More than 10% of the total combined voting power of all classes of stock of the Company or an Affiliate, the exercise price per share of the Shares covered by each ISO shall not be less than 110% of the Fair Market Value per share of the Class A Common Stock on the date of grant of the Option.

 

    5

     

    

 

(iii) Term of Option: For Participants
who own:

 

	 	A.	10% or less of the total combined voting power of all classes of stock of the Company or an Affiliate, each ISO shall terminate not more than ten years from the date of the grant or at such earlier time as the Option Agreement may provide; or

 

	 	B.	More than 10% of the total combined voting power of all classes of stock of the Company or an Affiliate, each ISO shall terminate not more than five years from the date of the grant or at such earlier time as the Option Agreement may provide.

 

(iv) Limitation on Yearly Exercise:
To the extent that aggregate Fair Market Value (determined on the date each ISO is granted) of the Shares with respect to which ISOs are
exercisable for the first time by the Participant in any calendar year exceeds $100,000, such Options shall be treated as Non-Qualified
Options even if denominated ISOs at grant.

 

(c) Except in connection
with a corporate transaction involving the Company (which term includes, without limitation, any stock dividend, stock split, extraordinary
cash dividend, recapitalization, reorganization, merger, consolidation, split-up, spin-off, combination or exchange of shares) or as otherwise
contemplated by Paragraph 24 below, the Company may not, without obtaining stockholder approval, (i) amend the terms of outstanding Options
to reduce the exercise price of such Options, (ii) cancel outstanding Options in exchange for Options that have an exercise price that
is less than the exercise price value of the original Options, or (iii) cancel outstanding Options that have an exercise price greater
than the Fair Market Value of a Share on the date of such cancellation in exchange for cash or other consideration.

 

	 	7.	TERMS AND CONDITIONS OF STOCK GRANTS.

 

Each Stock Grant to a Participant
shall state the principal terms in an Agreement duly executed by the Company and, to the extent required by law or requested by the Company,
by the Participant. The Agreement shall be in a form approved by the Administrator and shall contain terms and conditions which the Administrator
determines to be appropriate and in the best interest of the Company, subject to the following minimum standards:

 

(a) Each Agreement shall
state the purchase price per Share, if any, of the Shares covered by each Stock Grant, which purchase price shall be determined by the
Administrator on the date of the grant of the Stock Grant;

 

(b) Each Agreement shall
state the number of Shares to which the Stock Grant pertains;

 

(c) Each Agreement shall
include the terms of any right of the Company to restrict or reacquire the Shares subject to the Stock Grant, including the time period
or attainment of Performance Goals or such other performance criteria upon which such rights shall accrue and the purchase price therefor,
if any; and

 

(d) Dividends (other
than stock dividends to be issued pursuant to Paragraph 24 of the Plan) may accrue but shall not be paid prior to the time, and may be
paid only to the extent that, the restrictions or rights to reacquire the Shares subject to the Stock Grant lapse. Any entitlement to
dividend equivalents or similar entitlements will be established and administered either consistent with an exemption from, or in compliance
with the applicable requirements of Section 409A.

 

	 	8.	TERMS AND CONDITIONS OF OTHER STOCK-BASED AWARDS.

 

The Administrator shall have
the right to grant other Stock-Based Awards based upon the Class A Common Stock having such terms and conditions as the Administrator
may determine, including, without limitation, the grant of Shares based upon certain conditions, the grant of securities convertible into
Shares and the grant of SARs, phantom stock awards or stock units. The principal terms of each Stock-Based Award shall be set forth in
an Agreement, duly executed by the Company and, to the extent required by law or requested by the Company, by the Participant. The Agreement
shall be in a form approved by the Administrator and shall contain terms and conditions which the Administrator determines to be appropriate
and in the best interest of the Company. Each Agreement shall include the terms of any right of the Company including the right to terminate
the Stock-Based Award without the issuance of Shares, the terms of any vesting conditions, Performance Goals or events upon which Shares
shall be issued, provided that dividends (other than stock dividends to be issued pursuant to Paragraph 24 of the Plan) or dividend equivalents
may accrue but shall not be paid prior to and may be paid only to the extent that the Shares subject to the Stock-Based Award vest. Under
no circumstances may the Agreement covering SARs (a) have an exercise or base price (per share) that is less than the Fair Market Value
per share of Class A Common Stock on the date of grant or (b) expire more than ten years following the date of grant.

 

    6

     

    

 

	 	9.	PERFORMANCE-BASED AWARDS.

 

The Committee shall determine
whether, with respect to a performance period, the applicable Performance Goals have been met with respect to a given Participant and,
if they have, to so certify and ascertain the amount of the applicable Performance-Based Award. No Performance-Based Awards will be issued
for such performance period until such certification is made by the Committee. The number of Shares issued in respect of a Performance-Based
Award determined by the Committee for a performance period shall be paid to the Participant at such time as determined by the Committee
in its sole discretion after the end of such performance period, and any dividends (other than stock dividends to be issued pursuant to
Paragraph 24 of the Plan) or dividend equivalents that accrue shall only be paid in respect of the number of Shares earned in respect
of such Performance-Based Award.

 

	 	10.	EXERCISE OF OPTIONS AND ISSUE OF SHARES.

 

An Option (or any part or
installment thereof) shall be exercised by giving written notice to the Company or its designee (in a form acceptable to the Administrator,
which may include electronic notice), together with provision for payment of the aggregate exercise price in accordance with this Paragraph
for the Shares as to which the Option is being exercised, and upon compliance with any other condition(s) set forth in the Option Agreement.
Such notice shall be signed by the person exercising the Option (which signature may be provided electronically in a form acceptable to
the Administrator), shall state the number of Shares with respect to which the Option is being exercised and shall contain any representation
required by the Plan or the Option Agreement. Payment of the exercise price for the Shares as to which such Option is being exercised
shall be made (a) in United States dollars in cash or by check; or (b) at the discretion of the Administrator, through delivery
of shares of Class A Common Stock held for at least six months (if required to avoid negative accounting treatment) having a Fair Market
Value equal as of the date of the exercise to the aggregate cash exercise price for the number of Shares as to which the Option is being
exercised; or (c) at the discretion of the Administrator, by having the Company retain from the Shares otherwise issuable upon exercise
of the Option, a number of Shares having a Fair Market Value equal as of the date of exercise to the aggregate exercise price for the
number of Shares as to which the Option is being exercised; or (d) at the discretion of the Administrator, in accordance with a cashless
exercise program established with a securities brokerage firm, and approved by the Administrator; or (e) at the discretion of the Administrator,
by any combination of (a), (b), (c) and (d) above or (f) at the discretion of the Administrator, by payment of such other lawful consideration
as the Administrator may determine. Notwithstanding the foregoing, the Administrator shall accept only such payment on exercise of an
ISO as is permitted by Section 422.

 

The Company shall then reasonably
promptly deliver the Shares as to which such Option was exercised to the Participant (or to the Participant’s Survivors, as the
case may be). In determining what constitutes “reasonably promptly,” it is expressly understood that the issuance and delivery
of the Shares may be delayed by the Company if the Administrator determines it is necessary to comply with any law or regulation (including,
without limitation, federal securities laws) that requires the Company to take any action with respect to the Shares prior to their issuance.
The Shares shall, upon delivery, be fully paid, non-assessable Shares.

 

	 	11.	PAYMENT IN CONNECTION WITH THE ISSUANCE OF STOCK GRANTS AND STOCK-BASED AWARDS AND ISSUE OF SHARES.

 

Any Stock Grant or Stock-Based
Award requiring payment of a purchase price for the Shares as to which such Stock Grant or Stock-Based Award is being granted shall be
made (a) in United States dollars in cash or by check; or (b) at the discretion of the Administrator, through delivery of shares of Class
A Common Stock held for at least six months (if required to avoid negative accounting treatment) and having a Fair Market Value equal
as of the date of payment to the purchase price of the Stock Grant or Stock-Based Award; or (c) by delivery of a promissory note, if the
Board of Directors has expressly authorized the loan of funds to the Participant for the purpose of enabling or assisting the Participant
to effect such purchase; (d) at the discretion of the Administrator, by any combination of (a) through (c) above; or (e) at the discretion
of the Administrator, by payment of such other lawful consideration as the Administrator may determine.

 

The Company shall when required
by the applicable Agreement, reasonably promptly deliver the Shares as to which such Stock Grant or Stock-Based Award was made to the
Participant (or to the Participant’s Survivors, as the case may be), subject to any escrow provision set forth in the applicable
Agreement. In determining what constitutes “reasonably promptly,” it is expressly understood that the issuance and delivery
of the Shares may be delayed by the Company if the Administrator determines it is necessary to comply with any law or regulation (including,
without limitation, federal securities laws) which requires the Company to take any action with respect to the Shares prior to their issuance.

 

    7

     

    

 

	 	12.	RIGHTS AS A SHAREHOLDER.

 

No Participant to whom a Stock
Right has been granted shall have rights as a shareholder with respect to any Shares covered by such Stock Right except after due exercise
of an Option or issuance of Shares as set forth in any Agreement, tender of the aggregate exercise or purchase price, if any, for the
Shares being purchased and registration of the Shares in the Company’s share register in the name of the Participant.

 

	 	13.	ASSIGNABILITY AND TRANSFERABILITY OF STOCK RIGHTS.

 

By its terms, a Stock Right
granted to a Participant shall not be transferable by the Participant other than (i) by will or by the laws of descent and distribution,
or (ii) as approved by the Administrator in its discretion and set forth in the applicable Agreement provided that no Stock Right may
be transferred by a Participant for value. Notwithstanding the foregoing, an ISO transferred except in compliance with clause (i) above
shall no longer qualify as an ISO. The designation of a beneficiary of a Stock Right by a Participant, with the prior approval of the
Administrator and in such form as the Administrator shall prescribe, shall not be deemed a transfer prohibited by this Paragraph. Except
as provided above during the Participant’s lifetime a Stock Right shall only be exercisable by or issued to such Participant (or
his or her legal representative) and shall not be assigned, pledged or hypothecated in any way (whether by operation of law or otherwise)
and shall not be subject to execution, attachment or similar process. Any attempted transfer, assignment, pledge, hypothecation or other
disposition of any Stock Right or of any rights granted thereunder contrary to the provisions of this Plan, or the levy of any attachment
or similar process upon a Stock Right, shall be null and void.

 

	 	14.	EFFECT ON OPTIONS OF TERMINATION OF SERVICE OTHER THAN FOR CAUSE, OR DEATH OR DISABILITY.

 

Except as otherwise provided
in a Participant’s Option Agreement in the event of a termination of service (whether as an Employee, director or Consultant) with
the Company or an Affiliate before the Participant has exercised an Option, the following rules apply:

 

(a) A Participant who
ceases to be an Employee, director or Consultant of the Company or of an Affiliate (for any reason other than termination for Cause, Disability,
or death for which events there are special rules in Paragraphs 15, 16, and 17, respectively), may exercise any Option granted to such
Participant to the extent that the Option is exercisable on the date of such termination of service, but only within such term as the
Administrator has designated in a Participant’s Option Agreement.

 

(b) Except as provided
in Subparagraph (c) below, or Paragraph 16 or 17, in no event may an Option intended to be an ISO, be exercised later than three months
after the Participant’s termination of employment.

 

(c) The provisions of
this Paragraph, and not the provisions of Paragraph 16 or 17, shall apply to a Participant who subsequently becomes Disabled or dies after
the termination of employment, director status or consultancy; provided, however, in the case of a Participant’s Disability or death
within three months after the termination of employment, director status or consultancy, the Participant or the Participant’s Survivors
may exercise the Option within one year after the date of the Participant’s termination of service, but in no event after the date
of expiration of the term of the Option.

 

(d) Notwithstanding anything
herein to the contrary, if subsequent to a Participant’s termination of employment, termination of director status or termination
of consultancy, but prior to the exercise of an Option, the Administrator determines that, either prior or subsequent to the Participant’s
termination, the Participant engaged in conduct which would constitute Cause, then such Participant shall forthwith cease to have any
right to exercise any Option.

 

(e) A Participant to
whom an Option has been granted under the Plan who is absent from the Company or an Affiliate because of temporary disability (any disability
other than a Disability as defined in Paragraph 1 hereof), or who is on leave of absence for any purpose, shall not, during the period
of any such absence, be deemed, by virtue of such absence alone, to have terminated such Participant’s employment, director status
or consultancy with the Company or with an Affiliate, except as the Administrator may otherwise expressly provide; provided, however,
that, for ISOs, any leave of absence granted by the Administrator of greater than three months, unless pursuant to a contract or statute
that guarantees the right to reemployment, shall cause such ISO to become a Non-Qualified Option on the date that is six months following
the commencement of such leave of absence.

 

    8

     

    

 

(f) Except as required
by law or as set forth in a Participant’s Option Agreement, Options granted under the Plan shall not be affected by any change of
a Participant’s status within or among the Company and any Affiliates, so long as the Participant continues to be an Employee, director
or Consultant of the Company or any Affiliate.

 

	 	15.	EFFECT ON OPTIONS OF TERMINATION OF SERVICE FOR CAUSE.

 

Except as otherwise provided
in a Participant’s Option Agreement, the following rules apply if the Participant’s service (whether as an Employee, director
or Consultant) with the Company or an Affiliate is terminated for Cause prior to the time that all his or her outstanding Options have
been exercised:

 

(a) All outstanding and
unexercised Options as of the time the Participant is notified his or her service is terminated for Cause will immediately be forfeited.

 

(b) Cause is not limited
to events which have occurred prior to a Participant’s termination of service, nor is it necessary that the Administrator’s
finding of Cause occur prior to termination. If the Administrator determines, subsequent to a Participant’s termination of service
but prior to the exercise of an Option, that either prior or subsequent to the Participant’s termination the Participant engaged
in conduct which would constitute Cause, then the right to exercise any Option is forfeited.

 

	 	16.	EFFECT ON OPTIONS OF TERMINATION OF SERVICE FOR DISABILITY.

 

Except as otherwise provided
in a Participant’s Option Agreement:

 

(a) A Participant who
ceases to be an Employee, director or Consultant of the Company or of an Affiliate by reason of Disability may exercise any Option granted
to such Participant to the extent that the Option has become exercisable but has not been exercised on the date of the Participant’s
termination of service due to Disability; and in the event rights to exercise the Option accrue periodically, to the extent of a pro rata
portion through the date of the Participant’s termination of service due to Disability of any additional vesting rights that would
have accrued on the next vesting date had the Participant not become Disabled. The proration shall be based upon the number of days accrued
in the current vesting period prior to the date of the Participant’s termination of service due to Disability.

 

(b) A Disabled Participant
may exercise the Option only within the period ending one year after the date of the Participant’s termination of service due to
Disability, notwithstanding that the Participant might have been able to exercise the Option as to some or all of the Shares on a later
date if the Participant had not been terminated due to Disability and had continued to be an Employee, director or Consultant or, if earlier,
within the originally prescribed term of the Option.

 

(c) The Administrator
shall make the determination both of whether Disability has occurred and the date of its occurrence (unless a procedure for such determination
is set forth in another agreement between the Company and such Participant, in which case such procedure shall be used for such determination).
If requested, the Participant shall be examined by a physician selected or approved by the Administrator, the cost of which examination
shall be paid for by the Company.

 

	 	17.	EFFECT ON OPTIONS OF DEATH WHILE AN EMPLOYEE, DIRECTOR OR CONSULTANT.

 

Except as otherwise provided
in a Participant’s Option Agreement:

 

(a) In the event of the
death of a Participant while the Participant is an Employee, director or Consultant of the Company or of an Affiliate, such Option may
be exercised by the Participant’s Survivors to the extent that the Option has become exercisable but has not been exercised on the
date of death; and in the event rights to exercise the Option accrue periodically, to the extent of a pro rata portion through the date
of death of any additional vesting rights that would have accrued on the next vesting date had the Participant not died. The proration
shall be based upon the number of days accrued in the current vesting period prior to the Participant’s date of death.

 

(b) If the Participant’s
Survivors wish to exercise the Option, they must take all necessary steps to exercise the Option within one year after the date of death
of such Participant, notwithstanding that the decedent might have been able to exercise the Option as to some or all of the Shares on
a later date if he or she had not died and had continued to be an Employee, director or Consultant or, if earlier, within the originally
prescribed term of the Option.

 

    9

     

    

 

	 	18.	EFFECT OF TERMINATION OF SERVICE ON UNACCEPTED STOCK GRANTS AND STOCK-BASED AWARDS.

 

In the event of a termination
of service (whether as an Employee, director or Consultant) with the Company or an Affiliate for any reason before the Participant has
accepted a Stock Grant or a Stock-Based Award and paid the purchase price, if required, such grant shall terminate.

 

For purposes of this Paragraph
18 and Paragraph 19 below, a Participant to whom a Stock Grant or a Stock-Based Award has been issued under the Plan who is absent from
work with the Company or with an Affiliate because of temporary disability (any disability other than a Disability as defined in Paragraph
1 hereof), or who is on leave of absence for any purpose, shall not, during the period of any such absence, be deemed, by virtue of such
absence alone, to have terminated such Participant’s employment, director status or consultancy with the Company or with an Affiliate,
except as the Administrator may otherwise expressly provide.

 

In addition, for purposes
of this Paragraph 18 and Paragraph 19 below, any change of employment or other service within or among the Company and any Affiliates
shall not be treated as a termination of employment, director status or consultancy so long as the Participant continues to be an Employee,
director or Consultant of the Company or any Affiliate.

 

	 	19.	EFFECT ON STOCK GRANTS AND STOCK-BASED AWARDS OF TERMINATION OF SERVICE OTHER THAN FOR CAUSE, DEATh or DISABILITY.

 

Except as otherwise provided
in a Participant’s Agreement, in the event of a termination of service for any reason (whether as an Employee, director or Consultant),
other than termination for Cause, death or Disability for which there are special rules in Paragraphs 20, 21, and 22 below, before all
forfeiture provisions or Company rights of repurchase shall have lapsed, then the Company shall have the right to cancel or repurchase
that number of Shares subject to a Stock Grant or Stock-Based Award as to which the Company’s forfeiture or repurchase rights have
not lapsed.

 

	 	20.	EFFECT ON STOCK GRANTS AND STOCK-BASED AWARDS OF TERMINATION OF SERVICE FOR CAUSE.

 

Except as otherwise provided
in a Participant’s Agreement, the following rules apply if the Participant’s service (whether as an Employee, director or
Consultant) with the Company or an Affiliate is terminated for Cause:

 

(a) All Shares subject
to any Stock Grant or Stock-Based Award that remain subject to forfeiture provisions or as to which the Company shall have a repurchase
right shall be immediately forfeited to the Company as of the time the Participant is notified his or her service is terminated for Cause.

 

(b) Cause is not limited
to events which have occurred prior to a Participant’s termination of service, nor is it necessary that the Administrator’s
finding of Cause occur prior to termination. If the Administrator determines, subsequent to a Participant’s termination of service,
that either prior or subsequent to the Participant’s termination the Participant engaged in conduct which would constitute Cause,
then all Shares subject to any Stock Grant or Stock-Based Award that remained subject to forfeiture provisions or as to which the Company
had a repurchase right on the date of termination shall be immediately forfeited to the Company.

 

	 	21.	EFFECT ON STOCK GRANTS AND STOCK-BASED AWARDS OF TERMINATION OF SERVICE FOR DISABILITY.

 

Except as otherwise provided
in a Participant’s Agreement, the following rules apply if a Participant ceases to be an Employee, director or Consultant of the
Company or of an Affiliate by reason of Disability: to the extent the forfeiture provisions or the Company’s rights of repurchase
have not lapsed on the date of Disability, they shall be exercisable; provided, however, that in the event such forfeiture provisions
or rights of repurchase lapse periodically, such provisions or rights shall lapse to the extent of a pro rata portion of the Shares subject
to such Stock Grant or Stock-Based Award through the date of Disability as would have lapsed had the Participant not become Disabled.
The proration shall be based upon the number of days accrued prior to the date of Disability.

 

The Administrator shall make
the determination both as to whether Disability has occurred and the date of its occurrence (unless a procedure for such determination
is set forth in another agreement between the Company and such Participant, in which case such procedure shall be used for such determination).
If requested, the Participant shall be examined by a physician selected or approved by the Administrator, the cost of which examination
shall be paid for by the Company.

 

    10

     

    

 

	 	22.	EFFECT ON STOCK GRANTS AND STOCK-BASED AWARDS OF DEATH WHILE AN EMPLOYEE, DIRECTOR OR CONSULTANT.

 

Except as otherwise provided
in a Participant’s Agreement, the following rules apply in the event of the death of a Participant while the Participant is an Employee,
director or Consultant of the Company or of an Affiliate: to the extent the forfeiture provisions or the Company’s rights of repurchase
have not lapsed on the date of death, they shall be exercisable; provided, however, that in the event such forfeiture provisions or rights
of repurchase lapse periodically, such provisions or rights shall lapse to the extent of a pro rata portion of the Shares subject to such
Stock Grant or Stock-Based Award through the date of death as would have lapsed had the Participant not died. The proration shall be based
upon the number of days accrued prior to the Participant’s date of death.

 

(b) At the discretion
of the Administrator, the Company shall have received an opinion of its counsel that the Shares may be issued in compliance with the Securities
Act without registration thereunder.

 

	 	23.	DISSOLUTION OR LIQUIDATION OF THE COMPANY.

 

Upon the dissolution or liquidation
of the Company, all Options granted under this Plan which as of such date shall not have been exercised and all Stock Grants and Stock-Based
Awards which have not been accepted, to the extent required under the applicable Agreement, will terminate and become null and void; provided,
however, that if the rights of a Participant or a Participant’s Survivors have not otherwise terminated and expired, the Participant
or the Participant’s Survivors will have the right immediately prior to such dissolution or liquidation to exercise or accept any
Stock Right to the extent that the Stock Right is exercisable or subject to acceptance as of the date immediately prior to such dissolution
or liquidation. Upon the dissolution or liquidation of the Company, any outstanding Stock-Based Awards shall immediately terminate unless
otherwise determined by the Administrator or specifically provided in the applicable Agreement.

 

	 	24.	ADJUSTMENTS.

 

Upon the occurrence of any
of the following events, a Participant’s rights with respect to any Stock Right granted to such Participant hereunder shall be adjusted
as hereinafter provided, unless otherwise specifically provided in a Participant’s Agreement.

 

(a) Changes with respect
to Shares of Common Stock.

 

(i) If (1) the
shares of Common Stock shall be subdivided or combined into a greater or smaller number of shares or if the Company shall issue any shares
of Common Stock as a stock dividend on its outstanding Common Stock, or (2) additional shares or new or different shares or other
securities of the Company or other non-cash assets are distributed with respect to such shares of Common Stock, each Stock Right and the
number of shares of Common Stock deliverable thereunder shall be appropriately increased or decreased proportionately, and appropriate
adjustments shall be made including, in the exercise, base or purchase price per share and in the Performance Goals applicable to outstanding
Performance-Based Awards to reflect such events. The number of Shares subject to the limitations in Paragraphs 3(a), 3(b), 3(d) and 4(c)
shall also be proportionately adjusted upon the occurrence of such events.

 

(ii)  The Administrator may also
make adjustments of the type described in Paragraph 24(a) above to take into account distributions to stockholders other than those provided
for in Paragraphs 24(b) below, or any other event, if the Administrator determines that adjustments are appropriate to avoid distortion
in the operation of the Plan or any Award, having due regard for the qualification of ISOs under Section 422, the requirements of Section
409A, to the extent applicable.

 

    11

     

    

 

(ii) References in the Plan to Shares
will be construed to include any stock or securities resulting from an adjustment pursuant to this Paragraph 24(a).

 

(b) Corporate Transactions.
If the Company is to be consolidated with or acquired by another entity in a Corporate Transaction, the Administrator or the board of
directors of any entity assuming the obligations of the Company hereunder (the “Successor Board”), may, as to outstanding
Options, take any of the following actions: (i) make appropriate provision for the continuation of such Options by substituting on an
equitable basis for the Shares then subject to such Options either the consideration payable with respect to the outstanding shares of
Common Stock in connection with the Corporate Transaction or securities of any successor or acquiring entity; or (ii) upon written notice
to the Participants, provide that such Options must be exercised (either (A) to the extent then exercisable or (B) at the discretion of
the Administrator, any such Options being made partially or fully exercisable for purposes of this Subparagraph), within a specified number
of days of the date of such notice, at the end of which period such Options which have not been exercised shall terminate; or (iii) terminate
such Options in exchange for payment of an amount equal to the consideration payable upon consummation of such Corporate Transaction to
a holder of the number of shares of Common Stock into which such Option would have been exercisable (either (A) to the extent then exercisable
or, (B) at the discretion of the Administrator, any such Options being made partially or fully exercisable for purposes of this Subparagraph)
less the aggregate exercise price thereof. For purposes of determining the payments to be made pursuant to Subclause (iii) above,
in the case of a Corporate Transaction the consideration for which, in whole or in part, is other than cash, the consideration other than
cash shall be valued at the fair value thereof as determined in good faith by the Board of Directors. For the avoidance of doubt, if the
per share exercise price of an Option or portion thereof is equal to or greater than the Fair Market Value of one Share of Common Stock,
such Option may be cancelled with no payment due hereunder or otherwise in respect thereof.

 

With respect to outstanding
Stock Grants or Stock-Based Awards, the Administrator or the Successor Board, shall make appropriate provision for the continuation of
such Stock Grants or Stock-Based Awards on the same terms and conditions by substituting on an equitable basis for the Shares then subject
to such Stock Grants or Stock-Based Awards either the consideration payable with respect to the outstanding Shares of Common Stock in
connection with the Corporate Transaction or securities of any successor or acquiring entity. In lieu of the foregoing, in connection
with any Corporate Transaction, the Administrator may provide that each outstanding Stock Grant or Stock-Based Award shall be terminated
in exchange for payment of an amount equal to the consideration payable upon consummation of such Corporate Transaction to a holder of
the number of shares of Common Stock comprising such Stock Grant or Stock-Based Award (to the extent such Stock Grant or Stock-Based Award
is no longer subject to any forfeiture or repurchase rights then in effect or, at the discretion of the Administrator, all forfeiture
and repurchase rights being waived). For the avoidance of doubt, if the purchase or base price of a Stock Grant or Stock-Based Award or
portion thereof is equal to or greater than the Fair Market Value of one Share of Common Stock, such Stock Grant or Stock-Based Award,
as applicable, may be cancelled with no payment due hereunder or otherwise in respect thereof.

 

In taking any of the actions
permitted under this Paragraph 24(b), the Administrator shall not be obligated by the Plan to treat all Stock Rights, all Stock Rights
held by a Participant, or all Stock Rights of the same type, identically.

 

(c) Recapitalization
or Reorganization. In the event of a recapitalization or reorganization of the Company other than a Corporate Transaction pursuant
to which securities of the Company or of another corporation are issued with respect to the outstanding shares of Common Stock, a Participant
upon exercising an Option or accepting a Stock Grant after the recapitalization or reorganization shall be entitled to receive for the
price paid upon such exercise or acceptance if any, the number of replacement securities which would have been received if such Option
had been exercised or Stock Grant accepted prior to such recapitalization or reorganization.

 

    12

     

    

 

(d) Adjustments to
Stock-Based Awards. Upon the happening of any of the events described in Subparagraphs (a), (b) or (c) above, any outstanding Stock-Based
Award shall be appropriately adjusted to reflect the events described in such Subparagraphs. The Administrator or the Successor Board
shall determine the specific adjustments to be made under this Paragraph 24, including, but not limited to the effect of any, Corporate
Transaction and, subject to Paragraph 4, its determination shall be conclusive.

 

(e) Termination of
Awards upon Consummation of a Corporate Transaction. Except as the Administrator may otherwise determine, each Stock Right will automatically
terminate (and in the case of outstanding Shares of restricted Common Stock, will automatically be forfeited) immediately upon the consummation
of a Corporate Transaction, other than (i) any award that is assumed, continued or substituted pursuant to Paragraph 24(b) above, and
(ii) any cash award that by its terms, or as a result of action taken by the Administrator, continues following the consummation of the
Corporate Transaction.

 

	 	25.	ISSUANCES OF SECURITIES.

 

(a) Except as expressly
provided herein, no issuance by the Company of shares of stock of any class, or securities convertible into shares of stock of any class,
shall affect, and no adjustment by reason thereof shall be made with respect to, the number or price of shares subject to Stock Rights.
Except as expressly provided herein, no adjustments shall be made for dividends paid in cash or in property (including without limitation,
securities) of the Company prior to any issuance of Shares pursuant to a Stock Right.

 

(b) The Company will
not be obligated to issue any Shares pursuant to the Plan or to remove any restriction from Shares previously issued under the Plan until:
(i) the Company is satisfied that all legal matters in connection with the issuance of such Shares have been addressed and resolved; (ii)
if the outstanding Shares is at the time of issuance listed on any stock exchange or national market system, the Shares to be issued have
been listed or authorized to be listed on such exchange or system upon official notice of issuance; and (iii) all conditions of the award
have been satisfied or waived. The Company may require, as a condition to the exercise of an award or the issuance of Shares under an
award, such representations or agreements as counsel for the Company may consider appropriate to avoid violation of the Securities Act
of 1933, as amended, or any applicable state or non-U.S. securities law. Any Shares issued under the Plan will be evidenced in such manner
as the Administrator determines appropriate, including book-entry registration or delivery of stock certificates. In the event that the
Administrator determines that stock certificates will be issued in connection with Shares issued under the Plan, the Administrator may
require that such certificates bear an appropriate legend reflecting any restriction on transfer applicable to such Stock, and the Company
may hold the certificates pending the lapse of the applicable restrictions.

 

	 	26.	FRACTIONAL SHARES.

 

No fractional shares shall
be issued under the Plan and the person exercising a Stock Right shall receive from the Company cash in lieu of such fractional shares
equal to the Fair Market Value thereof.

 

	 	27.	WITHHOLDING.

 

In the event that any federal,
state, or local income taxes, employment taxes, Federal Insurance Contributions Act withholdings or other amounts are required by applicable
law or governmental regulation to be withheld from the Participant’s salary, wages or other remuneration in connection with the
issuance of a Stock Right or Shares under the Plan or for any other reason required by law, the Company may withhold from the Participant’s
compensation, if any, or may require that the Participant advance in cash to the Company, or to any Affiliate of the Company which employs
or employed the Participant, the statutory minimum amount of such withholdings unless a different withholding arrangement, including the
use of shares of the Company’s Common Stock or a promissory note, is authorized by the Administrator (and permitted by law). For
purposes hereof, the fair market value of the shares withheld for purposes of payroll withholding shall be determined in the manner set
forth under the definition of Fair Market Value provided in Paragraph 1 above, as of the most recent practicable date. If the Fair Market
Value of the shares withheld is less than the amount of payroll withholdings required, the Participant may be required to advance the
difference in cash to the Company or the Affiliate employer.

 

    13

     

    

 

	 	28.	TERMINATION OF THE PLAN.

 

The Plan will terminate on
April 13, 2031, the date which is ten years from the earlier of the date of its adoption by the Board of Directors and the date
of its approval by the shareholders of the Company. The Plan may be terminated at an earlier date by vote of the shareholders or the Board
of Directors of the Company; provided, however, that any such earlier termination shall not affect any Agreements executed prior to the
effective date of such termination. Termination of the Plan shall not affect any Stock Rights theretofore granted.

 

	 	29.	AMENDMENT OF THE PLAN AND AGREEMENTS.

 

The Plan may be amended by
the shareholders of the Company. The Plan may also be amended by the Administrator; provided that any amendment approved by the Administrator
which the Administrator determines is of a scope that requires shareholder approval shall be subject to obtaining such shareholder approval
including, without limitation, to the extent necessary to qualify any or all outstanding Stock Rights granted under the Plan or Stock
Rights to be granted under the Plan for favorable federal income tax treatment as may be afforded ISOs under Section 422 and to the extent
necessary to qualify the Shares issuable under the Plan for listing on any national securities exchange or quotation in any national automated
quotation system of securities dealers. Any modification or amendment of the Plan shall not, without the consent of a Participant, adversely
affect his or her rights under a Stock Right previously granted to such Participant, unless such amendment is required by applicable law
or necessary to preserve the economic value of such Stock Right. With the consent of the Participant affected, the Administrator may amend
outstanding Agreements in a manner which may be adverse to the Participant but which is not inconsistent with the Plan. In the discretion
of the Administrator, outstanding Agreements may be amended by the Administrator in a manner which is not adverse to the Participant.
Nothing in this Paragraph 30 shall limit the Administrator’s authority to take any action permitted pursuant to Paragraph 24.

 

	 	30.	EMPLOYMENT OR OTHER RELATIONSHIP.

 

Nothing in this Plan or any
Agreement shall be deemed to prevent the Company or an Affiliate from terminating the employment, consultancy or director status of a
Participant, nor to prevent a Participant from terminating his or her own employment, consultancy or director status or to give any Participant
a right to be retained in employment or other service by the Company or any Affiliate for any period of time.

 

	 	31.	SECTION 409A aND SECTION 422.

 

The Company intends that the
Plan and any Awards granted hereunder be exempt from or comply with Section 409A, to the extent applicable. The Company intends that ISOs
comply with Section 422, to the extent applicable. Any ambiguities in the Plan or any Award shall be construed to effect the intent as
described in this Paragraph 31.

 

If a Participant is a “specified
employee” as defined in Section 409A (and as applied according to procedures of the Company and its Affiliates) as of his or her
separation from service, to the extent any payment under this Plan or pursuant to an Award constitutes non-exempt deferred compensation
under Section 409A that is being paid by reason of separation from service, no payments due under this Plan or pursuant to an Award may
be made until the earlier of: (i) the first day of the seventh month following the Participant’s separation from service, or (ii)
the Participant’s date of death; provided, however, that any payments delayed during this six-month period shall be paid in the
aggregate in a lump sum, without interest, on the first day of the seventh month following the Participant’s separation from service.

 

    14

     

    

 

The Administrator shall administer
the Plan with a view toward ensuring that Awards under the Plan that are subject to Section 409A or Section 422, as applicable, comply
with the requirements thereof and that Options under the Plan be exempt from the requirements of Section 409A or compliant with Section
422, as applicable, but neither the Administrator nor any member of the Board of Directors, nor the Company nor any of its Affiliates,
nor any other person acting hereunder on behalf of the Company, the Administrator or the Board of Directors shall be liable to a Participant
or any Survivor by reason of the acceleration of any income, or the imposition of any additional tax or penalty, with respect to any Award,
whether by reason of a failure to satisfy the requirements of Section 409A or Section 422 or otherwise.

 

	 	32.	INDEMNITY.

 

Neither the Board of Directors
nor the Administrator, nor any members of either, nor any employees of the Company or any parent, subsidiary, or other Affiliate, shall
be liable for any act, omission, interpretation, construction or determination made in good faith in connection with their responsibilities
with respect to this Plan, and the Company hereby agrees to indemnify the members of the Board or Directors, the members of the Committee,
and the employees of the Company and its parent or subsidiaries in respect of any claim, loss, damage, or expense (including reasonable
counsel fees) arising from any such act, omission, interpretation, construction or determination to the full extent permitted by law.

 

	 	33.	CLAWBACK.

 

Notwithstanding anything to
the contrary contained in this Plan, the Company may recover from a Participant any compensation received from any Stock Right (whether
or not settled) or cause a Participant to forfeit any Stock Right (whether or not vested) in the event that the Company’s Clawback
Policy as then in effect is triggered.

 

	 	34.	WAIVER OF JURY TRIAL.

 

By accepting or being deemed to have accepted an
award under the Plan, each Participant waives (or will be deemed to have waived), to the maximum extent permitted under applicable law,
any right to a trial by jury in any action, proceeding or counterclaim concerning any rights under the Plan or any award, or under any
amendment, waiver, consent, instrument, document or other agreement delivered or which in the future may be delivered in connection therewith,
and agrees (or will be deemed to have agreed) that any such action, proceedings or counterclaim will be tried before a court and not before
a jury. By accepting or being deemed to have accepted an award under the Plan, each Participant certifies that no officer, representative,
or attorney of the Company has represented, expressly or otherwise, that the Company would not, in the event of any action, proceeding
or counterclaim, seek to enforce the foregoing waivers. Notwithstanding anything to the contrary in the Plan, nothing herein is to be
construed as limiting the ability of the Company and a Participant to agree to submit any dispute arising under the terms of the Plan
or any ward to binding arbitration or as limiting the ability of the Company to require any individual to agree to submit such disputes
to binding arbitration as a condition of receiving an award hereunder.

 

	 	35.	UNFUNDED OBLIGATIONS.

 

The Company’s obligations under the Plan
are unfunded, and no Participant will have any right to specific assets of the Company in respect of any award under the Plan. Participants
will be general unsecured creditors of the Company with respect to any amounts due or payable under the Plan.

 

	 	36.	GOVERNING LAW.

 

This Plan shall be construed
and enforced in accordance with the law of the State of Delaware.

 

    15

     

    

 

VICARIOUS SURGICAL INC.

 

Stock Option Grant Notice

Stock Option Grant under the Company’s

2021 Equity Incentive Plan

 

	1.	Name of Participant:

 

	2.	Date of Option Grant:

 

	3.	Type of Grant:

 

	4.	Maximum Number of Shares for which this Option is exercisable:

 

	5.	Exercise (purchase) price per share:

 

	6.	Option Expiration Date:

 

	7.	Vesting Schedule: This Option shall become exercisable (and the Shares issued upon exercise shall be vested) as follows provided the Participant is an Employee, director or Consultant of the Company or of an Affiliate on the applicable vesting date:

 

[INSERT VESTING PROVISIONS]

 

The foregoing rights are cumulative
and are subject to the other terms and conditions of this Agreement and the Plan.

 

The Company and the Participant
acknowledge receipt of this Stock Option Grant Notice and agree to the terms of the Stock Option Agreement attached hereto and incorporated
by reference herein, the Company’s 2021 Equity Incentive Plan and the terms of this Option Grant as set forth above.

 

	 	VICARIOUS SURGICAL INC. 
	 	 	 
	 	By:	 
	 	 	Name: 	                     
	 	 	Title:	 
	 	 	 	 
	 	 
	 	Participant

 

     

     

    

 

VICARIOUS SURGICAL INC. 

 

STOCK OPTION AGREEMENT - INCORPORATED TERMS
AND CONDITIONS

 

AGREEMENT (this “Agreement”)
made as of the date of grant set forth in the Stock Option Grant Notice by and between Vicarious Surgical Inc. (the “Company”),
a Delaware corporation, and the individual whose name appears on the Stock Option Grant Notice (the “Participant”).

 

WHEREAS, the Company desires
to grant to the Participant an Option to purchase shares of its Class A common stock, $0.0001 par value per share (the “Shares”),
under and for the purposes set forth in the Company’s 2021 Equity Incentive Plan (the “Plan”);

 

WHEREAS, the Company and the
Participant understand and agree that any terms used and not defined herein have the same meanings as in the Plan; and

 

WHEREAS, the Company and the
Participant each intend that the Option granted herein shall be of the type set forth in the Stock Option Grant Notice.

 

NOW, THEREFORE, in consideration
of the mutual covenants hereinafter set forth and for other good and valuable consideration, the parties hereto agree as follows:

 

1. GRANT OF OPTION.
The Company hereby grants to the Participant the right and option to purchase all or any part of an aggregate of the number of Shares
set forth in the Stock Option Grant Notice, on the terms and conditions and subject to all the limitations set forth herein, under United
States securities and tax laws, and in the Plan, which is incorporated herein by reference. The Participant acknowledges receipt of a
copy of the Plan.

 

2. EXERCISE PRICE.
The exercise price of the Shares covered by the Option shall be the amount per Share set forth in the Stock Option Grant Notice, subject
to adjustment, as provided in the Plan, in the event of a stock split, reverse stock split or other events affecting the holders of Shares
after the date hereof (the “Exercise Price”). Payment shall be made in accordance with Paragraph 10 of the Plan.

 

3. EXERCISABILITY
OF OPTION. Subject to the terms and conditions set forth in this Agreement and the Plan, the Option granted hereby shall become vested
and exercisable as set forth in the Stock Option Grant Notice and is subject to the other terms and conditions of this Agreement and the
Plan.

 

4. TERM OF OPTION.
This Option shall terminate on the Option Expiration Date as specified in the Stock Option Grant Notice and, if this Option is designated
in the Stock Option Grant Notice as an ISO and the Participant owns as of the date hereof more than 10% of the total combined voting power
of all classes of capital stock of the Company or an Affiliate, such date may not be more than five years from the date of this Agreement,
but shall be subject to earlier termination as provided herein or in the Plan.

 

If the Participant ceases to
be an Employee, director or Consultant of the Company or of an Affiliate for any reason other than the death or Disability of the Participant,
or termination of the Participant for Cause (the “Termination Date”), the Option to the extent then vested and exercisable
pursuant to Section 3 hereof as of the Termination Date, and not previously terminated in accordance with this Agreement, may be exercised
within three months after the Termination Date, or on or prior to the Option Expiration Date as specified in the Stock Option Grant Notice,
whichever is earlier, but may not be exercised thereafter except as set forth below. In such event, the unvested portion of the Option
shall not be exercisable and shall expire and be cancelled on the Termination Date.

 

     

     

    

 

If this Option is designated
in the Stock Option Grant Notice as an ISO and the Participant ceases to be an Employee of the Company or of an Affiliate but continues
after termination of employment to provide service to the Company or an Affiliate as a director or Consultant, this Option shall continue
to vest in accordance with Section 3 above as if this Option had not terminated until the Participant is no longer providing services
to the Company. In such case, this Option shall automatically convert and be deemed a Non-Qualified Option as of the date that is three
months from termination of the Participant’s employment and this Option shall continue on the same terms and conditions set forth herein
until such Participant is no longer providing service to the Company or an Affiliate.

 

Notwithstanding the foregoing,
in the event of the Participant’s Disability or death within three months after the Termination Date, the Participant or the Participant’s
Survivors may exercise the Option within one year after the Termination Date, but in no event after the Option Expiration Date as specified
in the Stock Option Grant Notice.

 

In the event the Participant’s
service is terminated by the Company or an Affiliate for Cause, the Participant’s right to exercise any unexercised portion of this
Option even if vested shall cease immediately as of the time the Participant is notified his or her service is terminated for Cause, and
this Option shall thereupon terminate. Notwithstanding anything herein to the contrary, if subsequent to the Participant’s termination,
but prior to the exercise of the Option, the Administrator determines that, either prior or subsequent to the Participant’s termination,
the Participant engaged in conduct which would constitute Cause, then the Participant shall immediately cease to have any right to exercise
the Option and this Option shall thereupon terminate.

 

In the event of the Disability
of the Participant, as determined in accordance with the Plan, the Option shall be exercisable within one year after the Participant’s
termination of service due to Disability or, if earlier, on or prior to the Option Expiration Date as specified in the Stock Option Grant
Notice. In such event, the Option shall be exercisable:

 

	 	(a)	to the extent that the Option has become exercisable but has not been exercised as of the date of the Participant’s termination of service due to Disability; and

 

	 	(b)	in the event rights to exercise the Option accrue periodically, to the extent of a pro rata portion through the date of the Participant’s termination of service due to Disability of any additional vesting rights that would have accrued on the next vesting date had the Participant not become Disabled. The proration shall be based upon the number of days accrued in the current vesting period prior to the date of the Participant’s termination of service due to Disability.

 

In the event of the death of
the Participant while an Employee, director or Consultant of the Company or of an Affiliate, the Option shall be exercisable by the Participant’s
Survivors within one year after the date of death of the Participant or, if earlier, on or prior to the Option Expiration Date as specified
in the Stock Option Grant Notice. In such event, the Option shall be exercisable:

 

	 	(x)	to the extent that the Option has become exercisable but has not been exercised as of the date of death; and

 

	 	(y)	in the event rights to exercise the Option accrue periodically, to the extent of a pro rata portion through the date of death of any additional vesting rights that would have accrued on the next vesting date had the Participant not died. The proration shall be based upon the number of days accrued in the current vesting period prior to the Participant’s date of death.

 

    2

     

    

 

5. METHOD OF EXERCISING
OPTION. Subject to the terms and conditions of this Agreement, the Option may be exercised by written notice to the Company or its
designee, in substantially the form of Exhibit A attached hereto (or in such other form acceptable to the Company, which may
include electronic notice). Such notice shall state the number of Shares with respect to which the Option is being exercised and shall
be signed by the person exercising the Option (which signature may be provided electronically in a form acceptable to the Company). Payment
of the Exercise Price for such Shares shall be made in accordance with Paragraph 10 of the Plan. The Company shall deliver such Shares
as soon as practicable after the notice shall be received, provided, however, that the Company may delay issuance of such Shares until
completion of any action or obtaining of any consent, which the Company deems necessary under any applicable law (including, without limitation,
state securities or “blue sky” laws). The Shares as to which the Option shall have been so exercised shall be registered in
the Company’s share register in the name of the person so exercising the Option (or, if the Option shall be exercised by the Participant
and if the Participant shall so request in the notice exercising the Option, shall be registered in the Company’s share register
in the name of the Participant and another person jointly, with right of survivorship) and shall be delivered as provided above to or
upon the written order of the person exercising the Option. In the event the Option shall be exercised, pursuant to Section 4 hereof,
by any person other than the Participant, such notice shall be accompanied by appropriate proof of the right of such person to exercise
the Option. All Shares that shall be purchased upon the exercise of the Option as provided herein shall be fully paid and nonassessable.

 

6. PARTIAL EXERCISE.
Exercise of this Option to the extent above stated may be made in part at any time and from time to time within the above limits, except
that no fractional share shall be issued pursuant to this Option.

 

7. NON-ASSIGNABILITY.
The Option shall not be transferable by the Participant otherwise than by will or by the laws of descent and distribution. If this Option
is a Non-Qualified Option then it may also be transferred pursuant to a qualified domestic relations order as defined by the Code or Title
I of the Employee Retirement Income Security Act or the rules thereunder. Except as provided above in this paragraph, the Option
shall be exercisable, during the Participant’s lifetime, only by the Participant (or, in the event of legal incapacity or incompetency,
by the Participant’s guardian or representative) and shall not be assigned, pledged or hypothecated in any way (whether by operation
of law or otherwise) and shall not be subject to execution, attachment or similar process. Any attempted transfer, assignment, pledge,
hypothecation or other disposition of the Option or of any rights granted hereunder contrary to the provisions of this Section 7, or the
levy of any attachment or similar process upon the Option shall be null and void.

 

8. NO RIGHTS AS STOCKHOLDER
UNTIL EXERCISE. The Participant shall have no rights as a stockholder with respect to Shares subject to this Agreement until registration
of the Shares in the Company’s share register in the name of the Participant. Except as is expressly provided in the Plan with respect
to certain changes in the capitalization of the Company, no adjustment shall be made for dividends or similar rights for which the record
date is prior to the date of such registration.

 

9. ADJUSTMENTS.
The Plan contains provisions covering the treatment of Options in a number of contingencies such as stock splits and mergers. Provisions
in the Plan for adjustment with respect to stock subject to Options and the related provisions with respect to successors to the business
of the Company are hereby made applicable hereunder and are incorporated herein by reference.

 

10. TAXES. The
Participant acknowledges and agrees that (i) any income or other taxes due from the Participant with respect to this Option or the Shares
issuable pursuant to this Option shall be the Participant’s responsibility; (ii) the Participant was free to use professional advisors
of his or her choice in connection with this Agreement, has received advice from his or her professional advisors in connection with this
Agreement, understands its meaning and import, and is entering into this Agreement freely and without coercion or duress; (iii) the Participant
has not received and is not relying upon any advice, representations or assurances made by or on behalf of the Company or any Affiliate
or any employee of or counsel to the Company or any Affiliate regarding any tax or other effects or implications of the Option, the Shares
or other matters contemplated by this Agreement; and (iv) neither the Administrator, the Company, its Affiliates, nor any of its officers
or directors, shall be held liable for any applicable costs, taxes, or penalties associated with the Option if, in fact, the Internal
Revenue Service were to determine that the Option constitutes deferred compensation under Section 409A of the Code.

 

    3

     

    

 

If this Option is designated
in the Stock Option Grant Notice as a Non-Qualified Option or if the Option is an ISO and is converted into a Non-Qualified Option and
such Non-Qualified Option is exercised, the Participant agrees that the Company may withhold from the Participant’s remuneration,
if any, the minimum statutory amount of federal, state and local withholding taxes attributable to such amount that is considered compensation
includable in such person’s gross income. At the Company’s discretion, the amount required to be withheld may be withheld
in cash from such remuneration, or in kind from the Shares otherwise deliverable to the Participant on exercise of the Option. The Participant
further agrees that, if the Company does not withhold an amount from the Participant’s remuneration sufficient to satisfy the Company’s
income tax withholding obligation, the Participant will reimburse the Company on demand, in cash, for the amount under-withheld.

 

11. PURCHASE FOR INVESTMENT.
Unless the offering and sale of the Shares to be issued upon the particular exercise of the Option shall have been effectively registered
under the Securities Act, the Company shall be under no obligation to issue the Shares covered by such exercise unless the Company has
determined that such exercise and issuance would be exempt from the registration requirements of the Securities Act and until the following
conditions have been fulfilled:

 

(a) The person(s) who exercise the Option
shall warrant to the Company, at the time of such exercise, that such person(s) are acquiring such Shares for their own respective accounts,
for investment, and not with a view to, or for sale in connection with, the distribution of any such Shares, in which event the person(s)
acquiring such Shares shall be bound by the provisions of the following legend which shall be endorsed upon any certificate(s) evidencing
the Shares issued pursuant to such exercise:

 

“The shares represented by this
certificate have been taken for investment and they may not be sold or otherwise transferred by any person, including a pledgee, unless
(1) either (a) a Registration Statement with respect to such shares shall be effective under the Securities Act of 1933, as amended, or
(b) the Company shall have received an opinion of counsel satisfactory to it that an exemption from registration under such Act is then
available, and (2) there shall have been compliance with all applicable state securities laws;” and

 

(b) If the Company so requires, the Company
shall have received an opinion of its counsel that the Shares may be issued upon such particular exercise in compliance with the Securities
Act without registration thereunder. Without limiting the generality of the foregoing, the Company may delay issuance of the Shares until
completion of any action or obtaining of any consent, which the Company deems necessary under any applicable law (including without limitation
state securities or “blue sky” laws).

 

12. RESTRICTIONS ON
TRANSFER OF SHARES.

 

(a) The Participant agrees that in the event
the Company proposes to offer for sale to the public any of its equity securities and such Participant is requested by the Company and
any underwriter engaged by the Company in connection with such offering to sign an agreement restricting the sale or other transfer of
Shares, then it will promptly sign such agreement and will not transfer, whether in privately negotiated transactions or to the public
in open market transactions or otherwise, any Shares or other securities of the Company held by him or her during such period as is determined
by the Company and the underwriters, not to exceed 180 days following the closing of the offering, plus such additional period of time
as may be required to comply with FINRA rules or similar rules thereto promulgated by another regulatory authority (such period, the “Lock-Up
Period”). Such agreement shall be in writing and in form and substance reasonably satisfactory to the Company and such underwriter
and pursuant to customary and prevailing terms and conditions. Notwithstanding whether the Participant has signed such an agreement, the
Company may impose stop-transfer instructions with respect to the Shares or other securities of the Company subject to the foregoing restrictions
until the end of the Lock-Up Period.

 

    4

     

    

 

(b) The Participant acknowledges and agrees
that neither the Company, its stockholders nor its directors and officers, has any duty or obligation to disclose to the Participant any
material information regarding the business of the Company or affecting the value of the Shares before, at the time of, or following a
termination of the service of the Participant by the Company, including, without limitation, any information concerning plans for the
Company to make a public offering of its securities or to be acquired by or merged with or into another firm or entity.

 

13. NO OBLIGATION
TO MAINTAIN RELATIONSHIP. The Participant acknowledges that: (i) the Company is not by the Plan or this Option obligated to continue
the Participant as an employee, director or Consultant of the Company or an Affiliate; (ii) the Plan is discretionary in nature and may
be suspended or terminated by the Company at any time; (iii) the grant of the Option is a one-time benefit which does not create any contractual
or other right to receive future grants of options, or benefits in lieu of options; (iv) all determinations with respect to any such future
grants, including, but not limited to, the times when options shall be granted, the number of shares subject to each option, the option
price, and the time or times when each option shall be exercisable, will be at the sole discretion of the Company; (v) the Participant’s
participation in the Plan is voluntary; (vi) the value of the Option is an extraordinary item of compensation which is outside the scope
of the Participant’s employment or consulting contract, if any; and (vii) the Option is not part of normal or expected compensation
for purposes of calculating any severance, resignation, redundancy, end of service payments, bonuses, long-service awards, pension or
retirement benefits or similar payments.

 

14. IF OPTION IS INTENDED
TO BE AN ISO. If this Option is designated in the Stock Option Grant Notice as an ISO so that the Participant (or the Participant’s
Survivors) may qualify for the favorable tax treatment provided to holders of Options that meet the standards of Section 422 of the Code
then any provision of this Agreement or the Plan which conflicts with the Code so that this Option would not be deemed an ISO is null
and void and any ambiguities shall be resolved so that the Option qualifies as an ISO. The Participant should consult with the Participant’s
own tax advisors regarding the tax effects of the Option and the requirements necessary to obtain favorable tax treatment under Section
422 of the Code, including, but not limited to, holding period requirements.

 

Notwithstanding the foregoing,
to the extent that the Option is designated in the Stock Option Grant Notice as an ISO and is not deemed to be an ISO pursuant to Section
422(d) of the Code because the aggregate Fair Market Value (determined as of the Date of Option Grant) of any of the Shares with respect
to which this ISO is granted becomes exercisable for the first time during any calendar year in excess of $100,000, the portion of the
Option representing such excess value shall be treated as a Non-Qualified Option and the Participant shall be deemed to have taxable income
measured by the difference between the then Fair Market Value of the Shares received upon exercise and the price paid for such Shares
pursuant to this Agreement.

 

Neither the Company nor any
Affiliate shall have any liability to the Participant, or any other party, if the Option (or any part thereof) that is intended to be
an ISO is not an ISO or for any action taken by the Administrator, including without limitation the conversion of an ISO to a Non-Qualified
Option.

 

15. NOTICE TO COMPANY
OF DISQUALIFYING DISPOSITION OF AN ISO. If this Option is designated in the Stock Option Grant Notice as an ISO then the Participant
agrees to notify the Company in writing immediately after the Participant makes a Disqualifying Disposition of any of the Shares acquired
pursuant to the exercise of the ISO. A Disqualifying Disposition is defined in Section 424(c) of the Code and includes any disposition
(including any sale) of such Shares before the later of (a) two years after the date the Participant was granted the ISO or (b) one year
after the date the Participant acquired Shares by exercising the ISO, except as otherwise provided in Section 424(c) of the Code. If the
Participant has died before the Shares are sold, these holding period requirements do not apply and no Disqualifying Disposition can occur
thereafter.

 

    5

     

    

 

16. NOTICES. Any
notices required or permitted by the terms of this Agreement or the Plan shall be given by recognized courier service, facsimile, registered
or certified mail, return receipt requested, addressed as follows:

 

If to the Company:

 

Vicarious Surgical Inc.

78 Fourth Avenue

Waltham, MA 0245

Attention: General Counsel

 

If to the Participant at the Participant’s
most recent address as shown in the employment or stock records of the Company. Any such notice shall be deemed to have been given upon
the earlier of receipt, one business day following delivery to a recognized courier service or three business days following mailing by
registered or certified mail.

 

17. GOVERNING LAW.
This Agreement shall be governed by and construed in accordance with the laws of the State of Delaware, without giving effect to
the conflict of law principles thereof. For the purpose of litigating any dispute that arises under this Agreement, the parties hereby
consent to exclusive jurisdiction in Massachusetts and agree that such litigation shall be conducted in the state courts of Massachusetts
or the federal courts of the United States for the District of Massachusetts.

 

18. BENEFIT OF AGREEMENT.
Subject to the provisions of the Plan and the other provisions hereof, this Agreement shall be for the benefit of and shall be binding
upon the heirs, executors, administrators, successors and assigns of the parties hereto.

 

19. ENTIRE AGREEMENT.
This Agreement, together with the Plan, embodies the entire agreement and understanding between the parties hereto with respect to the
subject matter hereof and supersedes all prior oral or written agreements and understandings relating to the subject matter hereof (with
the exception of acceleration of vesting provisions contained in any other agreement with the Company). No statement, representation,
warranty, covenant or agreement not expressly set forth in this Agreement shall affect or be used to interpret, change or restrict, the
express terms and provisions of this Agreement. Notwithstanding the foregoing in all events, this Agreement shall be subject to and governed
by the Plan.

 

20. MODIFICATIONS
AND AMENDMENTS. The terms and provisions of this Agreement may be modified or amended as provided in the Plan.

 

21. WAIVERS AND CONSENTS.
Except as provided in the Plan, the terms and provisions of this Agreement may be waived, or consent for the departure therefrom granted,
only by written document executed by the party entitled to the benefits of such terms or provisions. No such waiver or consent shall be
deemed to be or shall constitute a waiver or consent with respect to any other terms or provisions of this Agreement, whether or not similar.
Each such waiver or consent shall be effective only in the specific instance and for the purpose for which it was given, and shall not
constitute a continuing waiver or consent.

 

22. DATA PRIVACY.
By entering into this Agreement, the Participant: (i) authorizes the Company and each Affiliate, and any agent of the Company or any Affiliate
administering the Plan or providing Plan recordkeeping services, to disclose to the Company or any of its Affiliates such information
and data as the Company or any such Affiliate shall request in order to facilitate the grant of options and the administration of the
Plan; (ii) to the extent permitted by applicable law waives any data privacy rights he or she may have with respect to such information,
and (iii) authorizes the Company and each Affiliate to store and transmit such information in electronic form for the purposes set forth
in this Agreement.

 

[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]

 

    6

     

    

 

Exhibit A

 

NOTICE OF EXERCISE OF STOCK OPTION

 

Form for Shares registered in the United
States

 

	To:	Vicarious Surgical Inc.

 

IMPORTANT NOTICE: This form of Notice of Exercise may only be used
at such time as the Company has filed a Registration Statement with the Securities and Exchange Commission under which the issuance of
the Shares for which this exercise is being made is registered and such Registration Statement remains effective.

 

Ladies and Gentlemen:

 

I hereby exercise my Stock
Option to purchase _________ shares (the “Shares”) of the Class A common stock, $0.0001 par value, of Vicarious Surgical Inc.
(the “Company”), at the exercise price of $________ per share, pursuant to and subject to the terms of that Stock Option Grant
Notice dated _______________, 202_.

 

I understand the nature of
the investment I am making and the financial risks thereof. I am aware that it is my responsibility to have consulted with competent tax
and legal advisors about the relevant national, state and local income tax and securities laws affecting the exercise of the Option and
the purchase and subsequent sale of the Shares.

 

I am paying the option exercise
price for the Shares as follows:

 

_________________________________________

 

Please issue the Shares (check one):

 

☐ to me; or

 

☐ to me and ____________________________,
as joint tenants with right of survivorship,

 

at the following address:

 

	 	 
	 	 
	 	 

 

     

     

    

 

Exhibit A-1

 

My mailing address for stockholder
communications, if different from the address listed above, is:

 

	 	 
	 	 
	 	 

 

	 	Very truly yours,
	 	 
	 	 
	 	Participant (signature)
	 	 
	 	 
	 	Print Name
	 	 
	 	 
	 	Date
	 	 

 

     

     

    

 

Exhibit A-2

 

VICARIOUS SURGICAL INC.

 

Restricted Stock Unit Award Grant Notice

Restricted Stock Unit Award Grant under the Company’s

2021 Equity Incentive Plan

 

	1.	Name of Participant:

 

	2.	Date of Grant of

	 	Restricted Stock Unit Award:

 

	3.	Maximum Number of Shares underlying

	 	Restricted Stock Unit Award:

 

	4.	Vesting of Award: This Restricted Stock Unit Award shall vest as follows provided the Participant is an Employee, director or Consultant of the Company or of an Affiliate on the applicable vesting:

 

	Number of Restricted Stock Units	 	Vesting Date
	 	 	 
	 	 	 

 

[INSERT VESTING
PROVISIONS]

 

The Company and the Participant acknowledge receipt
of this Restricted Stock Unit Award Grant Notice and agree to the terms of the Restricted Stock Unit Agreement attached hereto and incorporated
by reference herein, the Company’s 2021 Equity Incentive Plan and the terms of this Restricted Stock Unit Award as set forth above.

 

	 	VICARIOUS SURGICAL INC.
	 	 	 
	 	By:	                  
	 	Name: 	 
	 	Title:	 
	 	 
	 	 
	 	Participant

 

     

     

    

 

VICARIOUS SURGICAL INC.

 

RESTRICTED STOCK UNIT AGREEMENT –

 

INCORPORATED TERMS AND CONDITIONS

 

AGREEMENT made as of the date
of grant set forth in the Restricted Stock Unit Award Grant Notice between Vicarious Surgical Inc. (the “Company”), a Delaware
corporation, and the individual whose name appears on the Restricted Stock Unit Award Grant Notice (the “Participant”).

 

WHEREAS, the Company has adopted
the 2021 Equity Incentive Plan (the “Plan”), to promote the interests of the Company by providing an incentive for Employees,
directors and Consultants of the Company and its Affiliates;

 

WHEREAS, pursuant to the provisions
of the Plan, the Company desires to grant to the Participant restricted stock units (“RSUs”) related to the Company’s
Class A common stock, $0.0001 par value per share (“Common Stock”), in accordance with the provisions of the Plan, all on
the terms and conditions hereinafter set forth; and

 

WHEREAS, the Company and the
Participant understand and agree that any terms used and not defined herein have the meanings ascribed to such terms in the Plan.

 

NOW, THEREFORE, in consideration
of the promises and the mutual covenants contained herein and for other good and valuable consideration, the receipt and sufficiency of
which are hereby acknowledged, the parties hereto hereby agree as follows:

 

1. Grant of Award.
The Company hereby grants to the Participant an award for the number of RSUs set forth in the Restricted Stock Unit Award Grant Notice
(the “Award”). Each RSU represents a contingent entitlement of the Participant to receive one share of Common Stock, on the
terms and conditions and subject to all the limitations set forth herein and in the Plan, which is incorporated herein by reference. The
Participant acknowledges receipt of a copy of the Plan.

 

2. Vesting of Award.

 

(a) Subject to the terms
and conditions set forth in this Agreement and the Plan, the Award granted hereby shall vest as set forth in the Restricted Stock Unit
Award Grant Notice and is subject to the other terms and conditions of this Agreement and the Plan. On each vesting date set forth in
the Restricted Stock Unit Award Grant Notice, the Participant shall be entitled to receive such number of shares of Common Stock equivalent
to the number of RSUs as set forth in the Restricted Stock Unit Award Grant Notice provided that the Participant is providing service
to the Company or an Affiliate on such vesting date. Such shares of Common Stock shall thereafter be delivered by the Company to the Participant
within five business days of the applicable vesting date and in accordance with this Agreement and the Plan.

 

(b) Except as otherwise
set forth in this Agreement, if the Participant ceases to be providing services for any reason by the Company or by an Affiliate (the
“Termination”) prior to a vesting date set forth in the Restricted Stock Unit Award Grant Notice, then as of the date on which
the Participant’s employment or service terminates, all unvested RSUs shall immediately be forfeited to the Company and this Agreement
shall terminate and be of no further force or effect.

 

     

     

    

 

3. Prohibitions on
Transfer and Sale. This Award (including any additional RSUs received by the Participant as a result of stock dividends, stock splits
or any other similar transaction affecting the Company’s securities without receipt of consideration) shall not be transferable
by the Participant otherwise than (i) by will or by the laws of descent and distribution, or (ii) pursuant to a qualified domestic relations
order as defined by the Internal Revenue Code or Title I of the Employee Retirement Income Security Act or the rules thereunder. Except
as provided in the previous sentence, the shares of Common Stock to be issued pursuant to this Agreement shall be issued, during the Participant’s
lifetime, only to the Participant (or, in the event of legal incapacity or incompetence, to the Participant’s guardian or representative).
This Award shall not be assigned, pledged or hypothecated in any way (whether by operation of law or otherwise) and shall not be subject
to execution, attachment or similar process. Any attempted transfer, assignment, pledge, hypothecation or other disposition of this Award
or of any rights granted hereunder contrary to the provisions of this Section 3, or the levy of any attachment or similar process upon
this Award shall be null and void.

 

4. Adjustments.
The Plan contains provisions covering the treatment of RSUs and shares of Common Stock in a number of contingencies such as stock splits.
Provisions in the Plan for adjustment with respect to this Award and the related provisions with respect to successors to the business
of the Company are hereby made applicable hereunder and are incorporated herein by reference.

 

5. Securities Law
Compliance. The Participant specifically acknowledges and agrees that any sales of shares of Common Stock shall be made in accordance
with the requirements of the Securities Act of 1933, as amended. The Company currently has an effective registration statement on file
with the Securities and Exchange Commission with respect to the Common Stock to be granted hereunder. The Company intends to maintain
this registration statement but has no obligation to do so. If the registration statement ceases to be effective for any reason, Participant
will not be able to transfer or sell any of the shares of Common Stock issued to the Participant pursuant to this Agreement unless exemptions
from registration or filings under applicable securities laws are available. Furthermore, despite registration, applicable securities
laws may restrict the ability of the Participant to sell his or her Common Stock, including due to the Participant’s affiliation
with the Company. The Company shall not be obligated to either issue the Common Stock or permit the resale of any shares of Common Stock
if such issuance or resale would violate any applicable securities law, rule or regulation.

 

6. Rights as a Stockholder.
The Participant shall have no right as a stockholder, including voting and dividend rights, with respect to the RSUs subject to this Agreement.

 

7. Incorporation of
the Plan. The Participant specifically understands and agrees that the RSUs and the shares of Common Stock to be issued under the
Plan will be issued to the Participant pursuant to the Plan, a copy of which Plan the Participant acknowledges he or she has read and
understands and by which Plan he or she agrees to be bound. The provisions of the Plan are incorporated herein by reference.

 

8. Tax
Liability of the Participant and Payment of Taxes. The Participant acknowledges and agrees that any income or other taxes due from
the Participant with respect to this Award or the shares of Common Stock to be issued pursuant to this Agreement or otherwise sold shall
be the Participant’s responsibility. Without limiting the foregoing, the Participant agrees that if under applicable law the Participant
will owe taxes at each vesting date on the portion of the Award then vested the Company shall be entitled to immediate payment from the
Participant of the amount of any tax or other amounts required to be withheld by the Company by applicable law or regulation. Any taxes
or other amounts due shall be paid, at the option of the Administrator as follows:

 

    2

     

    

 

(a) through reducing the
number of shares of Common Stock entitled to be issued to the Participant on the applicable vesting date in an amount equal to the statutory
minimum of the Participant’s total tax and other withholding obligations due and payable by the Company. Fractional shares will
not be retained to satisfy any portion of the Company’s withholding obligation. Accordingly, the Participant agrees that in the
event that the amount of withholding required would result in a fraction of a share being owed, that amount will be satisfied by withholding
the fractional amount from the Participant’s paycheck;

 

(b) requiring the Participant
to deposit with the Company an amount of cash equal to the amount determined by the Company to be required to be withheld with respect
to the statutory minimum amount of the Participant’s total tax and other withholding obligations due and payable by the Company
or otherwise withholding from the Participant’s paycheck an amount equal to such amounts due and payable by the Company; or

 

(c) if the Company believes
that the sale of shares can be made in compliance with applicable securities laws, authorizing, at a time when the Participant is not
in possession of material nonpublic information, the sale by the Participant on the applicable vesting date of such number of shares of
Common Stock as the Company instructs a registered broker to sell to satisfy the Company’s withholding obligation, after deduction
of the broker’s commission, and the broker shall be required to remit to the Company the cash necessary in order for the Company
to satisfy its withholding obligation. To the extent the proceeds of such sale exceed the Company’s withholding obligation the Company
agrees to pay such excess cash to the Participant as soon as practicable. In addition, if such sale is not sufficient to pay the Company’s
withholding obligation the Participant agrees to pay to the Company as soon as practicable, including through additional payroll withholding,
the amount of any withholding obligation that is not satisfied by the sale of shares of Common Stock. The Participant agrees to hold the
Company and the broker harmless from all costs, damages or expenses relating to any such sale. The Participant acknowledges that the Company
and the broker are under no obligation to arrange for such sale at any particular price. In connection with such sale of shares of Common
Stock, the Participant shall execute any such documents requested by the broker in order to effectuate the sale of shares of Common Stock
and payment of the withholding obligation to the Company. The Participant acknowledges that this paragraph is intended to comply with
Section 10b5-1(c)(1)(i)(B) under the Exchange Act.

 

It is the Company’s
intention that the Participant’s tax obligations under this Section 8 shall be satisfied through the procedure of Subsection (c)
above, unless the Company provides notice of an alternate procedure under this Section, in its discretion. The Company shall not deliver
any shares of Common Stock to the Participant until it is satisfied that all required withholdings have been made.

 

9. Participant Acknowledgements
and Authorizations.

 

The Participant acknowledges the following:

 

(a) The Company is not
by the Plan or this Award obligated to continue the Participant as an employee, director or consultant of the Company or an Affiliate.

 

(b) The Plan is discretionary
in nature and may be suspended or terminated by the Company at any time.

 

(c) The grant of this Award
is considered a one-time benefit and does not create a contractual or other right to receive any other award under the Plan, benefits
in lieu of awards or any other benefits in the future.

 

    3

     

    

 

(d) The Plan is a voluntary
program of the Company and future awards, if any, will be at the sole discretion of the Company, including, but not limited to, the timing
of any grant, the amount of any award, vesting provisions and the purchase price, if any.

 

(e) The value of this Award
is an extraordinary item of compensation outside of the scope of the Participant’s employment or consulting contract, if any. As
such the Award is not part of normal or expected compensation for purposes of calculating any severance, resignation, redundancy, end
of service payments, bonuses, long-service awards, pension or retirement benefits or similar payments. The future value of the shares
of Common Stock is unknown and cannot be predicted with certainty.

 

(f) The Participant (i)
authorizes the Company and each Affiliate and any agent of the Company or any Affiliate administering the Plan or providing Plan recordkeeping
services, to disclose to the Company or any of its Affiliates such information and data as the Company or any such Affiliate shall request
in order to facilitate the grant of the Award and the administration of the Plan; and (ii) authorizes the Company and each Affiliate to
store and transmit such information in electronic form for the purposes set forth in this Agreement.

 

10. Notices.
Any notices required or permitted by the terms of this Agreement or the Plan shall be given by recognized courier service, facsimile,
registered or certified mail, return receipt requested, addressed as follows:

 

If to the Company:

 

Vicarious Surgical Inc.

78 Fourth Avenue

Waltham, MA 0245

Attention: General Counsel

 

If to the Participant at the
Participant’s most recent address as shown in the employment or stock records of the Company. Any such notice shall be deemed to
have been given on the earliest of receipt, one business day following delivery by the sender to a recognized courier service, or three
business days following mailing by registered or certified mail.

 

11. Assignment and
Successors.

 

(a) This Agreement is personal
to the Participant and without the prior written consent of the Company shall not be assignable by the Participant otherwise than by will
or the laws of descent and distribution. This Agreement shall inure to the benefit of and be enforceable by the Participant’s legal
representatives.

 

(b) This Agreement shall
inure to the benefit of and be binding upon the Company and its successors and assigns.

 

12. Governing
Law. This Agreement shall be construed and enforced in accordance with the laws of the State of Delaware, without giving effect to
the conflict of law principles thereof. For the purpose of litigating any dispute that arises under this Agreement, whether at law or
in equity, the parties hereby consent to exclusive jurisdiction in Massachusetts and agree that such litigation will be conducted in the
state courts of Massachusetts or the federal courts of the United States for the District of Massachusetts.

 

13. Severability.
If any provision of this Agreement is held to be invalid or unenforceable by a court of competent jurisdiction, then such provision or
provisions shall be modified to the extent necessary to make such provision valid and enforceable, and to the extent that this is impossible,
then such provision shall be deemed to be excised from this Agreement, and the validity, legality and enforceability of the rest of this
Agreement shall not be affected thereby.

 

    4

     

    

 

14. Entire Agreement.
This Agreement, together with the Plan, constitutes the entire agreement and understanding between the parties hereto with respect to
the subject matter hereof and supersedes all prior oral or written agreements and understandings relating to the subject matter hereof.
No statement, representation, warranty, covenant or agreement not expressly set forth in this Agreement shall affect or be used to interpret,
change or restrict the express terms and provisions of this Agreement provided, however, in any event, this Agreement shall be subject
to and governed by the Plan.

 

15. Modifications
and Amendments; Waivers and Consents. The terms and provisions of this Agreement may be modified or amended as provided in the Plan.
Except as provided in the Plan, the terms and provisions of this Agreement may be waived, or consent for the departure therefrom granted,
only by written document executed by the party entitled to the benefits of such terms or provisions. No such waiver or consent shall be
deemed to be or shall constitute a waiver or consent with respect to any other terms or provisions of this Agreement, whether or not similar.
Each such waiver or consent shall be effective only in the specific instance and for the purpose for which it was given, and shall not
constitute a continuing waiver or consent.

 

16. Section 409A.
The Award of RSUs evidenced by this Agreement is intended to be exempt from the nonqualified deferred compensation rules of Section 409A
of the Code as a “short term deferral” (as that term is used in the final regulations and other guidance issued under Section
409A of the Code, including Treasury Regulation Section 1.409A-1(b)(4)(i)), and shall be construed accordingly.

 

17. Data Privacy.
By entering into this Agreement, the Participant: (i) authorizes the Company and each Affiliate, and any agent of the Company or any Affiliate
administering the Plan or providing Plan recordkeeping services, to disclose to the Company or any of its Affiliates such information
and data as the Company or any such Affiliate shall request in order to facilitate the grant of options and the administration of the
Plan; (ii) to the extent permitted by applicable law waives any data privacy rights he or she may have with respect to such information,
and (iii) authorizes the Company and each Affiliate to store and transmit such information in electronic form for the purposes set forth
in this Agreement.

 

[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]

 

 

5

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00343-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00343-of-00352.parquet"}]]